00000000|MMI|12.93|Hypoglycemia|C0020615|[dsyn]|["HYPOGLYCEMIA"-tx-1-"hypoglycemia"-noun-0]|TX|65/12|C18.452.394.984
00000000|MMI|3.68|Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2598112|[clna]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|88/14|
00000000|MMI|3.68|Date of admission|C1302393|[tmco]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|88/14|
00000000|MMI|3.65|Report status|C0586177|[fndg]|["Report status"-tx-1-"Report Status"-noun-0]|TX|113/13|
00000000|MMI|3.63|11-12|C3843712|[fndg]|["11-12"-tx-1-"11 12"-fraction-0]|TX|43/2,51/2|
00000000|MMI|3.59|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-1-"PUO"-noun-0]|TX|12/3|
00000000|MMI|3.49|6/4|C0442748|[fndg]|["6/4"-tx-1-"6/4"-fraction-0]|TX|104/3|
00000000|MMI|3.47|Diagnostic interview schedule|C0451119|[inpr]|["DIS"-tx-1-"DIS"-noun-0]|TX|82/3|
00000000|MMI|3.47|Discontinued|C1444662|[fndg]|["DIS"-tx-1-"DIS"-noun-0]|TX|82/3|
00000000|MMI|322.24|Portugal|C0032729|[geoa]|["PO"-tx-10-"PO"-noun-0,"PO"-tx-9-"PO"-noun-0,"PO"-tx-8-"PO"-noun-0,"PO"-tx-7-"PO"-noun-0,"PO"-tx-6-"PO"-noun-0,"PO"-tx-5-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0]|TX|2394/2;[2061/2],[2220/2];1884/2;[1289/2],[1565/2],[1684/2];1149/2;[807/2],[908/2],[1014/2];[421/2],[511/2],[545/2],[646/2]|Z01.542.727
00000000|MMI|126.80|Override|C1547671|[acty]|["Override"-tx-10-"override"-verb-0,"Override"-tx-9-"Override"-verb-0,"Override"-tx-9-"overridden"-noun-0,"Override"-tx-9-"override"-verb-0,"Override"-tx-8-"Override"-verb-0,"Override"-tx-8-"overridden"-noun-0,"Override"-tx-8-"override"-verb-0,"Override"-tx-7-"Override"-verb-0,"Override"-tx-7-"overridden"-noun-0,"Override"-tx-6-"override"-verb-0,"Override"-tx-5-"Override"-verb-0,"Override"-tx-5-"override"-verb-0,"Override"-tx-4-"Override"-verb-0,"Override"-tx-4-"overridden"-noun-0]|TX|2322/8;2167/8;2155/10;2030/8;1911/8;1899/10;1786/8;1592/8;1580/10;1117/8;[917/8],[934/8];748/8;572/8;560/10|
00000000|MMI|114.83|Oral|C0442027|[spco]|["PO"-tx-10-"PO"-noun-0,"PO"-tx-9-"PO"-noun-0,"PO"-tx-8-"PO"-noun-0,"PO"-tx-7-"PO"-noun-0,"PO"-tx-6-"PO"-noun-0,"PO"-tx-5-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0]|TX|2394/2;[2061/2],[2220/2];1884/2;[1289/2],[1565/2],[1684/2];1149/2;[807/2],[908/2],[1014/2];[421/2],[511/2],[545/2],[646/2]|
00000000|MMI|106.31|Patient Discharge|C0030685|[hlca]|["Discharge"-tx-52-"DISCHARGE"-noun-0,"Discharge"-tx-47-"DISCHARGE"-noun-0,"Discharge"-tx-11-"DISCHARGE"-noun-0,"Discharge"-tx-4-"DISCHARGE"-verb-0,"Discharge"-tx-1-"DISCHARGE"-noun-0,"Patient Discharge"-tx-1-"DISCHARGE PATIENT"-noun-0]|TX|5921/9;5635/9;2718/9;342/9;39/9;118/17|E02.204.125;E02.760.400.610;N02.421.192.125;N02.421.585.400.610;N04.590.233.727.210.125
00000000|MMI|106.31|Lasix|C0699992|[orch,phsu]|["Lasix"-tx-39-"lasix"-noun-0,"Lasix"-tx-36-"lasix"-noun-0,"Lasix"-tx-28-"lasix"-noun-0,"Lasix"-tx-17-"lasix"-noun-0,"Lasix"-tx-4-"LASIX"-noun-0]|TX|5262/5;5115/5;4745/5;3698/5;[518/5],[640/5]|D02.065.884.725.300;D02.092.146.807.300;D02.886.590.700.725.300
00000000|MMI|100.21|Hypoglycemia|C0020615|[dsyn]|["HYPOGLYCEMIA"-tx-45-"hypoglycemia"-noun-0,"HYPOGLYCEMIA"-tx-29-"hypoglycemia"-noun-0,"HYPOGLYCEMIA"-tx-24-"Hypoglycemia"-noun-0,"HYPOGLYCEMIA"-tx-21-"Hypoglycemia"-noun-0,"HYPOGLYCEMIA"-tx-12-"hypoglycemia"-noun-0,"HYPOGLYCEMIA"-tx-11-"hypoglycemia"-noun-0,"HYPOGLYCEMIA"-tx-11-"hypoglycemia"-noun-1]|TX|5588/12;4846/12;4324/12;4167/12;3304/12;[2695/12],[2787/12],[3167/12];[2695/12],[2787/12],[3167/12]|C18.452.394.984
00000000|MMI|72.92|Glipizide|C0017642|[orch,phsu]|["GLIPIZIDE"-tx-49-"glipizide"-noun-0,"GLIPIZIDE"-tx-44-"glipizide"-noun-0,"GLIPIZIDE"-tx-26-"glipizide"-noun-0,"GLIPIZIDE"-tx-9-"GLIPIZIDE"-noun-0]|TX|5793/9;5541/9;4598/9;[2070/9],[2210/9]|D02.886.590.795.500
00000000|MMI|66.02|Exanthema|C0015230|[sosy]|["RASH"-tx-45-"rash"-noun-0,"RASH"-tx-29-"rash"-noun-0,"RASH"-tx-28-"rash"-noun-0,"RASH"-tx-27-"rash"-noun-0,"RASH"-tx-9-"Rash"-noun-0,"RASH"-tx-7-"Rash"-noun-0,"RASH"-tx-4-"Rash"-noun-0]|TX|5569/4;4798/4;4727/4;4670/4;2294/4;1758/4;720/4|C17.800.257
00000000|MMI|63.07|Togo|C0040363|[geoa]|["TO"-tx-30-"to"-adv-0,"TO"-tx-28-"to"-adv-0,"TO"-tx-26-"to"-adv-0,"TO"-tx-18-"to"-adv-0]|TX|4873/2;4719/2;4483/2;3764/2|Z01.058.290.190.800
00000000|MMI|63.07|Tryptophanase|C0041260|[aapp,enzy]|["TO"-tx-30-"to"-adv-0,"TO"-tx-28-"to"-adv-0,"TO"-tx-26-"to"-adv-0,"TO"-tx-18-"to"-adv-0]|TX|4873/2;4719/2;4483/2;3764/2|D08.811.520.224.800
00000000|MMI|58.13|Blood Glucose|C0005802|[orch]|["Blood Glucose"-tx-48-"blood glucose"-noun-0,"blood sugars"-tx-44-"blood sugars"-noun-0,"Blood Sugar"-tx-43-"blood sugar"-noun-0,"blood sugars"-tx-9-"blood sugars"-noun-0]|TX|5709/13;5503/12;5416/11;2124/12|D09.546.359.448.500
00000000|MMI|57.79|Dominican Republic|C0013014|[geoa]|["DR"-tx-45-"Dr"-noun-0,"DR"-tx-39-"Dr"-noun-0,"DR"-tx-13-"Dr"-noun-0,"DR"-tx-10-"Dr"-noun-0]|TX|5608/2;5281/2;3333/2;2601/2|Z01.107.084.900.300;Z01.639.880.300
00000000|MMI|52.93|Obesity|C0028754|[dsyn]|["OBESE"-tx-20-"obese"-adj-0,"OBESITY"-tx-11-"obesity"-noun-0]|TX|4002/5;3003/7|C18.654.726.500;C23.888.144.699.500;E01.370.600.115.100.160.120.699.500;G07.100.100.160.120.699.500
00000000|MMI|50.16|Aspirin|C0004057|[orch,phsu]|["ASA"-tx-36-"ASA"-noun-0,"ASPIRIN"-tx-4-"ASPIRIN"-noun-0]|TX|5109/3;390/7|D02.455.426.559.389.657.410.595.176
00000000|MMI|50.05|Daily|C0332173|[tmco]|["Daily"-tx-41-"daily"-adv-0,"/day"-tx-10-"DAY"-noun-0,"Daily"-tx-10-"daily"-adj-0,"Daily"-tx-9-"DAILY"-adj-0,"Daily"-tx-8-"DAILY"-adv-0,"Daily"-tx-7-"DAILY"-adv-0,"Daily"-tx-6-"DAILY"-adj-0,"Daily"-tx-5-"DAILY"-adj-0,"Daily"-tx-4-"DAILY"-adj-0,"Daily"-tx-4-"DAILY"-adv-0]|TX|5346/5;2409/3;2449/5;2064/5;1887/5;[1292/5],[1568/5];1152/5;911/5;[424/5],[449/5],[548/5];[424/5],[449/5],[548/5]|
00000000|MMI|46.62|Physicians|C0031831|[prog]|["DR"-tx-45-"Dr"-noun-0,"DR"-tx-39-"Dr"-noun-0,"DR"-tx-13-"Dr"-noun-0,"DR"-tx-10-"Dr"-noun-0]|TX|5608/2;5281/2;3333/2;2601/2|M01.526.485.810;N02.360.810
00000000|MMI|45.79|Mongolia|C0026410|[geoa]|["MG"-tx-8-"MG"-noun-0,"MG"-tx-7-"MG"-noun-0,"MG"-tx-4-"MG"-noun-0]|TX|1881/2;1286/2;[508/2],[542/2]|Z01.252.474.651
00000000|MMI|44.41|Simvastatin|C0074554|[orch,phsu]|["SIMVASTATIN"-tx-6-"SIMVASTATIN"-noun-0,"SIMVASTATIN"-tx-5-"SIMVASTATIN"-noun-0]|TX|1094/11;1002/11|D02.455.426.559.847.638.400.900;D04.615.638.400.900
00000000|MMI|43.08|Lesotho|C0023376|[geoa]|["LT"-tx-14-"lt"-noun-0,"LT"-tx-7-"lt"-noun-0,"LT"-tx-4-"lt"-noun-0]|TX|3506/2;1312/2;469/2|Z01.058.290.175.400
00000000|MMI|42.38|Gout|C0018099|[dsyn]|["GOUT"-tx-32-"Gout"-noun-0,"GOUT"-tx-16-"gout"-noun-0,"GOUT"-tx-12-"gout"-noun-0]|TX|4917/4;3587/4;3269/4|C05.550.114.423;C05.799.414;C16.320.565.798.368;C18.452.648.798.368
00000000|MMI|42.35|Glyburide|C0017628|[orch,phsu]|["GLYBURIDE"-tx-24-"glyburide"-noun-0,"GLYBURIDE"-tx-21-"glyburide"-noun-0,"GLYBURIDE"-tx-14-"glyburide"-noun-0]|TX|4344/9;4223/9;3376/9|D02.886.590.795.575;D02.948.828.575
00000000|MMI|41.95|diagnosis aspect|C1704338|[qlco]|["diagnosis"-tx-11-"DIAGNOSIS"-noun-0]|TX|[2684/9],[2806/9]|x.x.x.x.x.x.x
00000000|MMI|39.00|Coding|C0009219|[ocac]|["code"-tx-4-"CODE"-noun-0,"code"-tx-4-"code"-noun-0]|TX|289/4;307/4|N04.452.758.708.200.400.500;N04.452.859.564.274;N05.715.360.300.715.500.249;N06.850.520.308.940.968.249
00000000|MMI|34.44|Diet|C0012155|[food]|["Diet"-tx-10-"DIET"-noun-0]|TX|[2413/4],[2455/4],[2522/4]|G07.203.650.240
00000000|MMI|33.77|Gastroesophageal reflux disease|C0017168|[dsyn]|["GERD"-tx-43-"GERD"-noun-0,"Gastrooesophageal reflux disease"-tx-11-"gastroesophageal reflux disease"-noun-0]|TX|5356/4;2957/31|C06.405.117.119.500.484
00000000|MMI|33.73|Atenolol|C0004147|[orch,phsu]|["ATENOLOL"-tx-36-"atenolol"-noun-0,"ATENOLOL"-tx-4-"ATENOLOL"-noun-0]|TX|5141/8;430/8|D02.033.100.624.698.070;D02.033.755.624.698.070;D02.092.063.624.698.070
00000000|MMI|33.69|Furosemide|C0016860|[orch,phsu]|["FUROSEMIDE"-tx-22-"furosemide"-noun-0,"FUROSEMIDE"-tx-4-"FUROSEMIDE"-noun-0]|TX|4276/10;526/10|D02.065.884.725.300;D02.092.146.807.300;D02.886.590.700.725.300
00000000|MMI|32.94|Pharmacogenomics Trial Characteristics Domain|C3714755|[inpr]|["PT"-tx-41-"pt"-noun-0,"PT"-tx-32-"pt"-noun-0,"PT"-tx-29-"pt"-noun-0,"PT"-tx-27-"pt"-noun-0,"PT"-tx-13-"Pt"-noun-0,"PT"-tx-12-"PT"-noun-0,"PT"-tx-9-"Pt"-noun-0,"PT"-tx-7-"Pt"-noun-0,"PT"-tx-4-"Pt"-noun-0]|TX|5326/2;4924/2;4783/2;4615/2;3326/2;3181/2;2243/2;1707/2;669/2|
00000000|MMI|32.94|Physical therapy (field)|C0699718|[bmod]|["PT"-tx-41-"pt"-noun-0,"PT"-tx-32-"pt"-noun-0,"PT"-tx-29-"pt"-noun-0,"PT"-tx-27-"pt"-noun-0,"PT"-tx-13-"Pt"-noun-0,"PT"-tx-12-"PT"-noun-0,"PT"-tx-9-"Pt"-noun-0,"PT"-tx-7-"Pt"-noun-0,"PT"-tx-4-"Pt"-noun-0]|TX|5326/2;4924/2;4783/2;4615/2;3326/2;3181/2;2243/2;1707/2;669/2|
00000000|MMI|31.28|100%|C3817553|[qnco]|["100%"-tx-43-"100"-integer-0,"100%"-tx-26-"100"-integer-0,"100%"-tx-9-"100"-integer-0,"100%"-tx-7-"100"-integer-0,"100%"-tx-4-"100"-integer-0]|TX|5474/3;4564/3;2145/3;[1316/3],[1520/3],[1675/3];[439/3],[473/3],[504/3]|
00000000|MMI|30.97|Niacin|C0027996|[phsu,vita]|["NIACIN"-tx-8-"NIACIN"-noun-0,"NIACIN"-tx-5-"NIACIN"-noun-0]|TX|1974/6;1070/6|D03.066.515.475;D03.383.725.547.475
00000000|MMI|30.21|Edema|C0013604|[fndg]|["SWELLING"-tx-9-"Swelling"-verb-0,"SWELLING"-tx-7-"Swelling"-verb-0,"SWELLING"-tx-4-"Swelling"-verb-0]|TX|2301/8;1765/8;727/8|C23.888.277
00000000|MMI|28.04|Food-Drug Interactions|C0242785|[dsyn]|["Interaction, Food-Drug"-tx-7-"Food/Drug Interaction"-noun-0,"Interaction, Food-Drug"-tx-6-"Food/Drug Interaction"-noun-0]|TX|1320/21;1158/21|G07.690.773.968.511
00000000|MMI|26.35|Citrus paradisi|C0947567|[plnt]|["grapefruit"-tx-6-"grapefruit"-noun-0]|TX|1198/10|B01.650.940.800.575.100.875.177.538
00000000|MMI|26.15|Diet therapy|C0012159|[hlca]|["Diet"-tx-10-"DIET"-noun-0]|TX|[2413/4],[2455/4],[2522/4]|E02.642.249
00000000|MMI|26.13|Disease|C0012634|[dsyn]|["condition"-tx-47-"CONDITION"-noun-0,"Disease"-tx-11-"disease"-noun-0,"condition"-tx-11-"Conditions"-noun-0]|TX|5645/9;3029/7;2816/10|C23.550.288
00000000|MMI|25.87|Colchicine|C0009262|[orch,phsu]|["COLCHICINE"-tx-34-"colchicine"-noun-0,"COLCHICINE"-tx-16-"colchicine"-noun-0,"COLCHICINE"-tx-12-"colchicine"-noun-0]|TX|5023/10;3626/10;3289/10|D03.132.225
00000000|MMI|23.89|Order (action)|C1705178|[acty]|["Order"-tx-52-"ORDERS"-verb-0,"Order"-tx-9-"order"-noun-0,"Order"-tx-7-"order"-noun-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-4-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5931/6;2200/5;1650/5;992/5;630/5;199/5;49/6|
00000000|MMI|23.89|Order (arrangement)|C1705176|[qlco]|["Order"-tx-52-"ORDERS"-verb-0,"Order"-tx-9-"order"-noun-0,"Order"-tx-7-"order"-noun-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-4-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5931/6;2200/5;1650/5;992/5;630/5;199/5;49/6|
00000000|MMI|23.89|Order (document)|C1705175|[inpr]|["Order"-tx-52-"ORDERS"-verb-0,"Order"-tx-9-"order"-noun-0,"Order"-tx-7-"order"-noun-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-4-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5931/6;2200/5;1650/5;992/5;630/5;199/5;49/6|
00000000|MMI|23.89|Order (taxonomic)|C1705177|[clas]|["Order"-tx-52-"ORDERS"-verb-0,"Order"-tx-9-"order"-noun-0,"Order"-tx-7-"order"-noun-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-4-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5931/6;2200/5;1650/5;992/5;630/5;199/5;49/6|
00000000|MMI|23.89|Permutation|C1882348|[qlco]|["Order"-tx-52-"ORDERS"-verb-0,"Order"-tx-9-"order"-noun-0,"Order"-tx-7-"order"-noun-0,"Order"-tx-5-"order"-noun-0,"Order"-tx-4-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5931/6;2200/5;1650/5;992/5;630/5;199/5;49/6|
00000000|MMI|23.89|Sequence of Planned Assessment Schedule|C3889825|[inpr]|["ORDER"-tx-52-"ORDERS"-verb-0,"ORDER"-tx-9-"order"-noun-0,"ORDER"-tx-7-"order"-noun-0,"ORDER"-tx-5-"order"-noun-0,"ORDER"-tx-4-"order"-noun-0,"ORDER"-tx-1-"ORDER"-noun-0,"ORDER"-tx-1-"ORDERS"-verb-0]|TX|5931/6;2200/5;1650/5;992/5;630/5;199/5;49/6|
00000000|MMI|23.28|Doctor of Medicine|C1512018|[inpr]|["M.D."-tx-50-"M.D"-noun-0,"M.D."-tx-7-"M.D"-noun-0,"M.D."-tx-5-"M.D"-noun-0,"M.D."-tx-4-"M.D"-noun-0,"M.D."-tx-2-"M.D"-noun-0]|TX|5867/3;1642/3;984/3;622/3;277/3|
00000000|MMI|22.85|Home visit (procedure)|C0020043|[hlca]|["home services"-tx-48-"services home"-noun-0,"home services"-tx-4-"Home services"-noun-0]|TX|5682/8,5695/4;325/4,333/8|N04.452.758.307
00000000|MMI|22.61|Panama|C0030266|[geoa]|["PM"-tx-52-"PM"-noun-0,"PM"-tx-1-"PM"-adj-0]|TX|5904/2;156/2|Z01.107.169.772
00000000|MMI|22.61|Rabbi|C0684010|[prog]|["R."-tx-16-"R"-noun-0,"R."-tx-11-"R"-noun-0]|TX|3594/1;3108/1|M01.526.799.500
00000000|MMI|22.51|Awareness|C0004448|[menp]|["Aware"-tx-6-"aware"-adj-0,"Aware"-tx-5-"aware"-adj-0]|TX|1127/5;758/5|F02.463.188.150
00000000|MMI|20.88|Hydroxymethylglutaryl-CoA Reductase Inhibitors|C0360714|[orch,phsu]|["Statin"-tx-36-"statin"-noun-0]|TX|5123/6|D27.505.519.186.071.202.370;D27.505.519.389.370;D27.505.954.557.500.202.370
00000000|MMI|20.88|Walking (activity)|C0080331|[dora]|["Walking"-tx-10-"Walking"-noun-0]|TX|2552/7|G11.427.590.530.568.900;G11.427.590.530.698.277.937;I03.350.937;I03.450.642.845.940
00000000|MMI|19.52|Surgical aspects|C0038895|[ftcn]|["operations"-tx-11-"OPERATIONS"-noun-0]|TX|3037/10|x.x.x.x.x.x.x
00000000|MMI|19.40|Body Weight|C0005910|[orga]|["Weight"-tx-10-"weight"-noun-0]|TX|2442/6|C23.888.144;E01.370.600.115.100.160.120;E05.041.124.160.750;G07.100.100.160.120;G07.700.320.249.314.120
00000000|MMI|19.37|Betamethasone valerate|C0750848|[orch,phsu]|["BETAMETHASONE VALERATE"-tx-7-"BETAMETHASONE VALERATE"-noun-0]|TX|1417/22|D04.808.745.432.769.199.150;D04.808.908.093.150
00000000|MMI|19.36|Cerebroside-Sulfatase|C0007804|[aapp,enzy]|["ASA"-tx-36-"ASA"-noun-0]|TX|5109/3|D08.811.277.352.827.070.250
00000000|MMI|18.36|To|C1883351|[qlco]|["To"-tx-30-"to"-adv-0,"To"-tx-28-"to"-adv-0,"To"-tx-26-"to"-adv-0,"To"-tx-18-"to"-adv-0]|TX|4873/2;4719/2;4483/2;3764/2|
00000000|MMI|18.28|Patients|C0030705|[podg]|["*^patient"-tx-30-"patient"-noun-0,"*^patient"-tx-26-"Patient"-noun-0,"*^patient"-tx-10-"Patient"-noun-0]|TX|4888/7;4460/7;2419/7|M01.643
00000000|MMI|18.15|Docusate Sodium|C0243237|[orch,phsu]|["DOCUSATE SODIUM"-tx-4-"DOCUSATE SODIUM"-noun-0]|TX|486/15|D02.241.081.337.759.249
00000000|MMI|18.15|Nicotinamide adenine dinucleotide (NAD)|C0027270|[bacs,nnon,phsu]|["NAD+"-tx-20-"NAD"-noun-0]|TX|3895/3|D03.438.759.646.138.694;D08.211.589;D13.695.667.138.694;D13.695.827.068.694
00000000|MMI|17.45|Patient Monitoring|C0030695|[hlca]|["monitor"-tx-29-"monitor"-noun-0,"monitor"-tx-10-"monitor"-verb-0]|TX|4786/7;2368/7|E01.370.520
00000000|MMI|17.01|Tablet Dosage Form|C0039225|[bodm]|["TAB"-tx-7-"TAB"-noun-0,"TAB"-tx-5-"TAB"-noun-0]|TX|1561/3;904/3|D26.255.830
00000000|MMI|16.96|Hypertensive disease|C0020538|[dsyn]|["HTN"-tx-36-"HTN"-noun-0,"HTN"-tx-12-"HTN"-noun-0]|TX|5085/3;3189/3|C14.907.489
00000000|MMI|16.85|Colace|C0282139|[orch,phsu]|["Colace"-tx-4-"COLACE"-noun-0]|TX|477/6|D02.241.081.337.759.249
00000000|MMI|16.72|District of Columbia|C0012764|[geoa]|["D.C."-tx-1-"D/C"-noun-0]|TX|195/3|Z01.107.567.875.500.210;Z01.433.429
00000000|MMI|16.69|Diastole|C0012000|[clna]|["Diastolic"-tx-12-"diastolic"-adj-0]|TX|3206/9|G09.330.190.541.295;G11.427.590.540.554.250;G11.427.590.540.570.295
00000000|MMI|16.38|Allergy to sulfonamides|C0038757|[dsyn]|["allergy sulfa"-tx-27-"allergy sulfa"-noun-0,"SULFA ALLERGY"-tx-10-"sulfa allergy"-noun-0,"allergy sulfa"-tx-9-"allergy Sulfa"-noun-0,"allergy sulfa"-tx-7-"allergy Sulfa"-noun-0,"allergy sulfa"-tx-4-"allergy Sulfa"-noun-0]|TX|4633/7,4644/5;2347/13;2262/7,2273/5;1726/7,1737/5;688/7,699/5|
00000000|MMI|16.23|Indication of (contextual qualifier)|C0392360|[idcn]|["Reason"-tx-10-"Reason"-noun-0,"Reason"-tx-9-"Reason"-noun-0,"Reason"-tx-8-"Reason"-noun-0,"Reason"-tx-6-"Reason"-noun-0,"Reason"-tx-5-"Reason"-noun-0]|TX|2311/6;2019/6;1775/6;1106/6;737/6|
00000000|MMI|16.16|Body Fluid Discharge|C0012621|[bdsu]|["Discharge"-tx-52-"DISCHARGE"-noun-0,"Discharge"-tx-47-"DISCHARGE"-noun-0,"Discharge"-tx-11-"DISCHARGE"-noun-0,"Discharge"-tx-4-"DISCHARGE"-verb-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|5921/9;5635/9;2718/9;342/9;39/9|
00000000|MMI|16.16|Discharge, body substance|C2926602|[bdsu]|["Discharge"-tx-52-"DISCHARGE"-noun-0,"Discharge"-tx-47-"DISCHARGE"-noun-0,"Discharge"-tx-11-"DISCHARGE"-noun-0,"Discharge"-tx-4-"DISCHARGE"-verb-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|5921/9;5635/9;2718/9;342/9;39/9|
00000000|MMI|15.98|Additional|C1524062|[ftcn]|["Added"-tx-9-"added"-verb-0,"Added"-tx-8-"added"-verb-0,"Added"-tx-7-"added"-verb-0,"Added"-tx-5-"added"-verb-0,"Added"-tx-4-"added"-verb-0]|TX|2176/5;1920/5;1601/5;943/5;581/5|
00000000|MMI|15.42|Demerol|C0935966|[orch,phsu]|["Demerol"-tx-11-"Demerol"-noun-0]|TX|2646/7|D03.066.399.450;D03.383.621.349.450
00000000|MMI|15.42|Eating|C0013470|[orgf]|["Eat"-tx-26-"eat"-verb-0]|TX|4486/3|G07.203.650.593.260;G07.700.620.260;G10.261.326.240
00000000|MMI|15.42|Electrocardiogram|C0013798|[fndg]|["EKG"-tx-21-"EKG"-noun-0]|TX|4102/3|E01.370.370.380.240;E01.370.405.240
00000000|MMI|15.42|Electrocardiography|C1623258|[diap]|["EKG"-tx-21-"EKG"-noun-0]|TX|4102/3|E01.370.370.380.240;E01.370.405.240
00000000|MMI|15.42|Left Ventricular Hypertrophy|C0149721|[dsyn]|["LVH"-tx-12-"LVH"-noun-0]|TX|3198/3|C14.280.195.400;C23.300.775.250.400
00000000|MMI|15.42|Levothyroxine Sodium|C0079691|[aapp,horm,phsu]|["Laevothyroxine sodium"-tx-5-"LEVOTHYROXINE SODIUM"-noun-0]|TX|776/20|D06.472.931.812;D12.125.072.050.767
00000000|MMI|14.15|Fat-Restricted Diet|C0242970|[topp]|["Low fat diet, NOS"-tx-10-"Low fat DIET"-noun-0]|TX|2469/3,2487/8|E02.642.249.260;G07.203.650.240.260
00000000|MMI|14.12|Ankle|C0003086|[bsoj]|["Ankle"-tx-16-"ankle"-noun-0]|TX|3596/5|A01.378.610.250.149
00000000|MMI|14.12|Ankle joint structure|C0003087|[bsoj]|["Ankle"-tx-16-"ankle"-noun-0]|TX|3596/5|A02.835.583.378.062
00000000|MMI|14.12|Lipitor|C0593906|[orch,phsu]|["Lipitor"-tx-8-"LIPITOR"-noun-0]|TX|1853/7|D03.383.129.578.075;D10.251.450.200
00000000|MMI|14.12|Norvasc|C0162712|[orch,phsu]|["Norvasc"-tx-36-"norvasc"-noun-0]|TX|5152/7|D03.383.725.203.065
00000000|MMI|14.12|Synthroid|C0728762|[aapp,phsu]|["Synthroid"-tx-5-"SYNTHROID"-noun-0]|TX|764/9|D06.472.931.812;D12.125.072.050.767
00000000|MMI|14.08|Creatinine|C0010294|[bacs,orch]|["CREATININE"-tx-37-"creatinine"-noun-0]|TX|5178/10|D03.383.129.308.207
00000000|MMI|14.08|Proton Pump Inhibitors|C0358591|[phsu]|["PPI"-tx-43-"PPI"-noun-0]|TX|5368/3|D27.505.519.389.848
00000000|MMI|14.08|prepulse inhibition activity|C0871125|[phsf]|["PPI"-tx-43-"PPI"-noun-0]|TX|5368/3|G11.561.600.812.500
00000000|MMI|14.01|Coronary Arteriosclerosis|C0010054|[dsyn]|["coronary artery disease"-tx-11-"coronary artery disease"-noun-0]|TX|3013/23|C14.280.647.250.260;C14.907.137.126.339;C14.907.585.250.260
00000000|MMI|14.01|Coronary Artery Disease|C1956346|[dsyn]|["CORONARY ARTERY DISEASE"-tx-11-"coronary artery disease"-noun-0]|TX|3013/23|C14.280.647.250.260;C14.907.137.126.339;C14.907.585.250.260
00000000|MMI|13.94|Atorvastatin calcium|C0286650|[orch,phsu]|["ATORVASTATIN CALCIUM"-tx-9-"ATORVASTATIN CALCIUM"-noun-0]|TX|1998/20|D03.383.129.578.075;D10.251.450.200
00000000|MMI|13.94|Checking (action)|C1283174|[acty]|["Check"-tx-43-"Check"-verb-0,"Check"-tx-30-"check"-verb-0,"Check"-tx-26-"check"-verb-0,"Checked"-tx-25-"checked"-verb-0]|TX|5405/5;4876/5;4508/5;4409/7|
00000000|MMI|13.92|Pain|C0030193|[sosy]|["PAIN"-tx-5-"Pain"-noun-0]|TX|845/4|C10.597.617;C23.888.592.612;F02.830.816.444;G11.561.600.810.444
00000000|MMI|13.90|Probability|C0033204|[qnco]|["Probable"-tx-7-"PROBABLE"-adj-0]|TX|1717/8|E05.318.740.600;G17.680;N05.715.360.750.625;N06.850.520.830.600
00000000|MMI|13.89|Lebanon|C0023190|[geoa]|["LE"-tx-20-"LE"-noun-0]|TX|4027/2|Z01.252.245.500.450
00000000|MMI|13.63|Beginning|C0439659|[tmco]|["Begin"-tx-44-"begin"-verb-0,"Start"-tx-26-"start"-verb-0,"Start"-tx-9-"start"-noun-0]|TX|5535/5;4592/5;2108/5|
00000000|MMI|13.63|Swelling|C0038999|[fndg]|["SWELLING"-tx-9-"Swelling"-verb-0,"SWELLING"-tx-7-"Swelling"-verb-0,"SWELLING"-tx-4-"Swelling"-verb-0]|TX|2301/8;1765/8;727/8|
00000000|MMI|13.09|Delayed Release Dosage Form|C1707664|[bodm]|["DR"-tx-45-"Dr"-noun-0,"DR"-tx-39-"Dr"-noun-0,"DR"-tx-13-"Dr"-noun-0,"DR"-tx-10-"Dr"-noun-0]|TX|5608/2;5281/2;3333/2;2601/2|
00000000|MMI|13.09|Device to Subject Relationship Domain|C3540849|[inpr]|["DR"-tx-45-"Dr"-noun-0,"DR"-tx-39-"Dr"-noun-0,"DR"-tx-13-"Dr"-noun-0,"DR"-tx-10-"Dr"-noun-0]|TX|5608/2;5281/2;3333/2;2601/2|
00000000|MMI|13.09|Doctor - Title|C2348314|[cnce]|["Dr."-tx-45-"Dr"-noun-0,"Dr."-tx-39-"Dr"-noun-0,"Dr."-tx-13-"Dr"-noun-0,"Dr."-tx-10-"Dr"-noun-0]|TX|5608/2;5281/2;3333/2;2601/2|
00000000|MMI|13.08|+2|C0740116|[qnco]|["+2"-tx-48-"2"-integer-0,"+2"-tx-31-"2"-integer-0,"+2"-tx-11-"2"-fraction-0,"+2"-tx-10-"2"-integer-0]|TX|5734/1;4914/1;2611/1;2528/1|
00000000|MMI|13.08|2+|C3833492|[fndg]|["2+"-tx-48-"2"-integer-0,"2+"-tx-31-"2"-integer-0,"2+"-tx-11-"2"-fraction-0,"2+"-tx-10-"2"-integer-0]|TX|5734/1;4914/1;2611/1;2528/1|
00000000|MMI|13.08|2+ Score|C2827735|[qnco]|["2+"-tx-48-"2"-integer-0,"2+"-tx-31-"2"-integer-0,"2+"-tx-11-"2"-fraction-0,"2+"-tx-10-"2"-integer-0]|TX|5734/1;4914/1;2611/1;2528/1|
00000000|MMI|13.08|2+ Score, WHO|C2981700|[clas]|["2+"-tx-48-"2"-integer-0,"2+"-tx-31-"2"-integer-0,"2+"-tx-11-"2"-fraction-0,"2+"-tx-10-"2"-integer-0]|TX|5734/1;4914/1;2611/1;2528/1|
00000000|MMI|13.04|ALYREF gene|C1425988|[gngm]|["REF"-tx-9-"ref"-noun-0,"REF"-tx-7-"ref"-noun-0,"REF"-tx-5-"ref"-noun-0,"REF"-tx-4-"ref"-noun-0]|TX|2225/3;1689/3;1019/3;651/3|
00000000|MMI|12.92|Empty (qualifier)|C1880497|[qlco]|["Free"-tx-46-"Freed"-verb-0,"Free"-tx-14-"Freed"-adj-0,"Free"-tx-11-"Freed"-verb-0,"Empty"-tx-7-"empty"-adj-0]|TX|5612/5;3337/5;2605/5;1365/5|
00000000|MMI|12.87|Hospital admission|C0184666|[hlca]|["Admission"-tx-19-"Admission"-noun-0,"Admission"-tx-17-"admission"-noun-0,"Admission"-tx-11-"Admission"-noun-0,"Admit"-tx-11-"ADMIT"-verb-0]|TX|3853/9;3667/9;2775/9;2678/5|
00000000|MMI|12.85|1+|C3816745|[fndg]|["1+"-tx-47-"1"-integer-0,"1+"-tx-23-"1"-integer-0,"1+"-tx-7-"1"-integer-0,"1+"-tx-5-"1"-integer-0]|TX|5675/1;4321/1;1559/1;902/1|
00000000|MMI|12.85|1+ Score|C2827734|[qnco]|["1+"-tx-47-"1"-integer-0,"1+"-tx-23-"1"-integer-0,"1+"-tx-7-"1"-integer-0,"1+"-tx-5-"1"-integer-0]|TX|5675/1;4321/1;1559/1;902/1|
00000000|MMI|12.85|1+ Score, WHO|C2981698|[clas]|["1+"-tx-47-"1"-integer-0,"1+"-tx-23-"1"-integer-0,"1+"-tx-7-"1"-integer-0,"1+"-tx-5-"1"-integer-0]|TX|5675/1;4321/1;1559/1;902/1|
00000000|MMI|12.69|Diabetes Mellitus|C0011849|[dsyn]|["DIABETES MELLITUS"-tx-11-"diabetes mellitus"-noun-0]|TX|2937/17|C18.452.394.750;C19.246
00000000|MMI|12.69|Psoriasis|C0033860|[dsyn]|["PSORIASIS"-tx-11-"psoriasis"-noun-0]|TX|2991/9|C17.800.859.675
00000000|MMI|12.61|Recent|C0332185|[tmco]|["Recent"-tx-17-"recent"-adj-0,"Recent"-tx-16-"recent"-adj-0,"Recently"-tx-15-"recently"-adv-0,"Recently"-tx-12-"recently"-adv-0]|TX|3660/6;3544/6;3519/8;3245/8|
00000000|MMI|12.61|Congestive heart failure|C0018802|[dsyn]|["CHF"-tx-39-"CHF"-noun-0,"CHF"-tx-17-"CHF"-noun-0,"CHF"-tx-12-"CHF"-noun-0,"CONGESTIVE HEART FAILURE"-tx-11-"congestive heart failure"-noun-0]|TX|5251/3;3681/3;3216/3;2910/24|
00000000|MMI|12.54|Dose number:Number:Point in time:^Patient:Quantitative|C1114758|[clna]|["Dose #"-tx-34-"dose"-noun-0,"Dose #"-tx-14-"dose"-noun-0,"Dose number"-tx-8-"Number Doses"-noun-0,"Dose number"-tx-7-"Number Doses"-noun-0]|TX|5043/4;3368/4;1806/6,1816/5;1460/6,1470/5|
00000000|MMI|12.26|Alert|C3665546|[ftcn]|["Alert"-tx-9-"Alert"-adj-0,"Alert"-tx-8-"Alert"-adj-0,"Alert"-tx-7-"Alert"-adj-0,"Alert"-tx-4-"Alert"-adj-0]|TX|2149/5;1893/5;1574/5;554/5|
00000000|MMI|12.26|Alert:Type:Point in time:^Patient:Nominal|C3669039|[clna]|["Alert"-tx-9-"Alert"-adj-0,"Alert"-tx-8-"Alert"-adj-0,"Alert"-tx-7-"Alert"-adj-0,"Alert"-tx-4-"Alert"-adj-0]|TX|2149/5;1893/5;1574/5;554/5|
00000000|MMI|12.26|Consciousness clear|C0239110|[fndg]|["ALERT"-tx-9-"Alert"-adj-0,"ALERT"-tx-8-"Alert"-adj-0,"ALERT"-tx-7-"Alert"-adj-0,"ALERT"-tx-4-"Alert"-adj-0]|TX|2149/5;1893/5;1574/5;554/5|
00000000|MMI|12.26|Magnesium Cation|C2346927|[elii,phsu]|["Mg++"-tx-8-"MG"-noun-0,"Mg++"-tx-7-"MG"-noun-0,"Mg++"-tx-4-"MG"-noun-0]|TX|1881/2;1286/2;[508/2],[542/2]|
00000000|MMI|12.26|Milligram percent|C1960952|[qnco]|["mg %"-tx-8-"MG"-noun-0,"mg %"-tx-7-"MG"-noun-0,"mg %"-tx-4-"MG"-noun-0]|TX|1881/2;1286/2;[508/2],[542/2]|
00000000|MMI|12.26|mg/dL|C0439269|[qnco]|["mg%"-tx-8-"MG"-noun-0,"mg%"-tx-7-"MG"-noun-0,"mg%"-tx-4-"MG"-noun-0]|TX|1881/2;1286/2;[508/2],[542/2]|
00000000|MMI|12.15|Possible diagnosis|C2362652|[qlco]|["Possible"-tx-27-"possible"-adj-0,"Possibly"-tx-22-"Possibly"-adv-0,"Possible"-tx-9-"POSSIBLE"-adj-0,"Possible"-tx-4-"POSSIBLE"-adj-0]|TX|4624/8;4234/8;2253/8;679/8|
00000000|MMI|11.75|Educational process of instructing|C0039401|[edac]|["Instruction"-tx-7-"Instruction"-noun-0,"Instruction"-tx-6-"Instruction"-noun-0]|TX|1342/11;1180/11|I02.903
00000000|MMI|11.39|Isosorbide Mononitrate|C0064079|[orch,phsu]|["ISOSORBIDE MONONITRATE"-tx-7-"ISOSORBIDE MONONITRATE"-noun-0]|TX|1251/22|x.x.x.x
00000000|MMI|11.33|Infantile Neuroaxonal Dystrophy|C0270724|[dsyn]|["PLAN"-tx-47-"PLAN"-noun-0]|TX|5669/4|C10.228.140.744
00000000|MMI|11.29|Glucose|C0017725|[bacs,orch,phsu]|["GLUCOSE"-tx-49-"glucose"-noun-0]|TX|5764/7|D09.546.359.448
00000000|MMI|11.28|BaseLine dental cement|C0168634|[bodm]|["baseline"-tx-21-"baseline"-noun-0]|TX|4147/8|x.x.x.x
00000000|MMI|11.28|Stomach|C0038351|[bpoc]|["STOMACH"-tx-7-"stomach"-noun-0]|TX|1371/7|A03.556.875.875
00000000|MMI|11.28|Symmetrical dyschromatosis of extremities|C0406775|[cgab,dsyn]|["RAD"-tx-20-"rad"-noun-0]|TX|3984/3|x.x.x.x
00000000|MMI|11.28|Coronary heart disease|C0010068|[dsyn]|["Coronary (artery) disease"-tx-11-"coronary artery disease"-noun-0]|TX|3013/23|C14.280.647.250;C14.907.585.250
00000000|MMI|11.27|ERF protein, human|C1308189|[aapp,bacs]|["PE-2"-tx-20-"2 PE"-noun-0]|TX|4021/1,4037/2|x.x.x.x
00000000|MMI|11.26|Dilatation and Curettage|C0012358|[topp]|["D & C"-tx-1-"D/C"-noun-0]|TX|195/3|E04.157.310;E04.950.300.299
00000000|MMI|11.22|IFIH1 protein, human|C1310463|[aapp,enzy]|["MDA-5"-tx-9-"mda 5"-noun-0]|TX|2040/3,2080/1|x.x.x.x
00000000|MMI|11.21|ARID1A protein, human|C0675390|[aapp,bacs]|["hELD"-tx-24-"Held"-adj-0]|TX|4339/4|x.x.x.x
00000000|MMI|11.21|Costa Rica|C0010182|[geoa]|["CRI"-tx-37-"CRI"-noun-0]|TX|5163/3|Z01.107.169.238
00000000|MMI|11.20|Sodium|C0037473|[bacs,elii]|["SODIUM"-tx-10-"Sodium"-noun-0]|TX|2535/6|D01.268.549.750;D01.268.557.650;D01.552.528.850;D01.552.547.725;x.x.x.x
00000000|MMI|11.17|Turkmenistan|C0041403|[geoa]|["TX"-tx-17-"tx"-noun-0]|TX|3685/2|Z01.252.100.940;Z01.586.200.940;Z01.586.950.940
00000000|MMI|11.16|Coughing|C0010200|[sosy]|["COUGH"-tx-18-"cough"-noun-0]|TX|3730/5|C08.618.248;C23.888.852.293
00000000|MMI|11.16|Fetal Membranes, Premature Rupture|C0015944|[patf]|["PROM"-tx-20-"prom"-noun-0]|TX|3945/4|C13.703.420.339
00000000|MMI|10.46|Reaction|C0443286|[ftcn]|["Reaction"-tx-9-"reactions"-noun-0,"Reaction"-tx-7-"reactions"-noun-0,"Reaction"-tx-4-"reactions"-noun-0]|TX|2280/9;1744/9;706/9|
00000000|MMI|10.29|FABP6 protein, human|C1435727|[aapp,bacs]|["GT"-tx-26-"gt"-noun-0,"GT"-tx-14-"gt"-noun-0,"GT"-tx-9-"gt"-noun-0]|TX|4561/2;3479/2;2142/2|
00000000|MMI|10.06|Diagnosis|C0011900|[fndg]|["Diagnosed"-tx-12-"diagnosed"-verb-0,"DIAGNOSIS"-tx-11-"DIAGNOSIS"-noun-0]|TX|3254/9;[2684/9],[2806/9]|E01
00000000|MMI|10.01|Preventive monitoring|C0150369|[hlca]|["Monitoring"-tx-48-"monitoring"-verb-0,"monitor"-tx-29-"monitor"-noun-0,"monitor"-tx-10-"monitor"-verb-0]|TX|5723/10;4786/7;2368/7|
00000000|MMI|9.99|Abortion consent:Finding:Point in time:^Patient:Document|C2360836|[clna]|["Patient"-tx-30-"patient"-noun-0,"Patient"-tx-26-"Patient"-noun-0,"Patient"-tx-10-"Patient"-noun-0]|TX|4888/7;4460/7;2419/7|
00000000|MMI|9.99|Hysterectomy consent:Finding:Point in time:^Patient:Document|C2360838|[clna]|["Patient"-tx-30-"patient"-noun-0,"Patient"-tx-26-"Patient"-noun-0,"Patient"-tx-10-"Patient"-noun-0]|TX|4888/7;4460/7;2419/7|
00000000|MMI|9.99|Sterilization consent:Finding:Point in time:^Patient:Document|C2360840|[clna]|["Patient"-tx-30-"patient"-noun-0,"Patient"-tx-26-"Patient"-noun-0,"Patient"-tx-10-"Patient"-noun-0]|TX|4888/7;4460/7;2419/7|
00000000|MMI|9.95|Abdomen|C0000726|[blor]|["abd"-tx-20-"abd"-noun-0]|TX|3998/3|A01.923.047
00000000|MMI|9.95|Allergy Specialty|C0002111|[bmod]|["Allergy"-tx-11-"ALLERGY"-noun-0]|TX|2637/7|H02.403.044
00000000|MMI|9.95|Complication Aspects|C1171258|[patf]|["complications"-tx-11-"Complications"-noun-0]|TX|2842/13|x.x.x
00000000|MMI|9.95|Drug Allergy|C0013182|[dsyn]|["allergy Medicine"-tx-27-"allergy medicine"-noun-0]|TX|4692/16|C20.543.206;C25.100.468
00000000|MMI|9.95|Methods aspects|C0025664|[inpr]|["procedures"-tx-11-"PROCEDURES"-noun-0]|TX|3052/10|x.x.x
00000000|MMI|9.91|Lymphotoxin-Alpha, human|C3887647|[aapp,imft]|["LT"-tx-14-"lt"-noun-0,"LT"-tx-7-"lt"-noun-0,"LT"-tx-4-"lt"-noun-0]|TX|3506/2;1312/2;469/2|
00000000|MMI|9.91|Structure of left thigh|C0230426|[bpoc]|["LT"-tx-14-"lt"-noun-0,"LT"-tx-7-"lt"-noun-0,"LT"-tx-4-"lt"-noun-0]|TX|3506/2;1312/2;469/2|
00000000|MMI|9.69|Free (available (qualifier))|C1996904|[qlco]|["Free"-tx-46-"Freed"-verb-0,"Free"-tx-14-"Freed"-adj-0,"Free"-tx-11-"Freed"-verb-0]|TX|5612/5;3337/5;2605/5|
00000000|MMI|9.69|Free of (attribute)|C0332296|[ftcn]|["free"-tx-46-"Freed"-verb-0,"free"-tx-14-"Freed"-adj-0,"free"-tx-11-"Freed"-verb-0]|TX|5612/5;3337/5;2605/5|
00000000|MMI|9.56|Basal Diet|C2983588|[food]|["DIET"-tx-10-"DIET"-noun-0]|TX|[2413/4],[2455/4],[2522/4]|
00000000|MMI|9.56|Diet (animal life circumstance)|C3668949|[food]|["Diet"-tx-10-"DIET"-noun-0]|TX|[2413/4],[2455/4],[2522/4]|
00000000|MMI|9.56|Special Diet Therapy|C1519433|[topp]|["DIET"-tx-10-"DIET"-noun-0]|TX|[2413/4],[2455/4],[2522/4]|
00000000|MMI|9.53|Hyzaar|C0721010|[orch,phsu]|["Hyzaar"-tx-36-"hyzaar"-noun-0,"Hyzaar"-tx-7-"HYZAAR"-noun-0]|TX|5132/6;[1505/6],[1660/6]|
00000000|MMI|9.51|mg/mg|C1319635|[qnco]|["mg/mg"-tx-7-"MG MG"-noun-0,"mg/mg"-tx-4-"MG MG"-noun-0]|TX|[1517/2,1524/2],[1672/2,1679/2];418/2,443/2|
00000000|MMI|9.45|Instruction [Publication Type]|C0302828|[inpr]|["instructions"-tx-9-"Instructions"-noun-0,"Instruction"-tx-7-"Instruction"-noun-0,"Instruction"-tx-6-"Instruction"-noun-0]|TX|2094/12;1342/11;1180/11|
00000000|MMI|9.45|Instructions|C1442085|[idcn]|["Instructions"-tx-9-"Instructions"-noun-0,"instruction"-tx-7-"Instruction"-noun-0,"instruction"-tx-6-"Instruction"-noun-0]|TX|2094/12;1342/11;1180/11|
00000000|MMI|9.38|Admission activity|C0809949|[hlca]|["Admission"-tx-19-"Admission"-noun-0,"Admission"-tx-17-"admission"-noun-0,"Admission"-tx-11-"Admission"-noun-0]|TX|3853/9;3667/9;2775/9|
00000000|MMI|9.20|Patient Condition Code - Stable|C1547311|[inpr]|["Stable"-tx-47-"Stable"-adj-0,"Stable"-tx-44-"stable"-adj-0,"Stable"-tx-37-"stable"-adj-0]|TX|5656/6;5491/6;5169/6|
00000000|MMI|9.20|Stable status|C0205360|[qlco]|["STABLE"-tx-47-"Stable"-adj-0,"STABLE"-tx-44-"stable"-adj-0,"STABLE"-tx-37-"stable"-adj-0]|TX|5656/6;5491/6;5169/6|
00000000|MMI|9.20|Increase|C0442805|[ftcn]|["Increase"-tx-49-"increase"-noun-0,"Increased"-tx-25-"increased"-verb-0,"Increased"-tx-22-"increased"-adj-0]|TX|5784/8;4441/9;4266/9|
00000000|MMI|9.18|week|C0439230|[tmco]|["WEEK"-tx-49-"week"-noun-0,"WEEKS"-tx-18-"weeks"-noun-0,"WEEK"-tx-14-"week"-noun-0]|TX|5777/4;3747/5;3420/4|
00000000|MMI|9.06|Home environment|C0442519|[cnce]|["HOME"-tx-36-"home"-noun-0,"house"-tx-10-"House"-noun-0]|TX|5096/4;[2461/5],[2497/5]|
00000000|MMI|9.06|Subject Continuance|C2826258|[evnt]|["CONT"-tx-43-"cont"-noun-0,"CONT"-tx-39-"Cont"-noun-0,"CONT"-tx-36-"cont"-noun-0]|TX|5363/4;5257/4;5091/4|
00000000|MMI|9.02|Possible|C0332149|[qlco]|["Possible"-tx-27-"possible"-adj-0,"Possible"-tx-9-"POSSIBLE"-adj-0,"Possible"-tx-4-"POSSIBLE"-adj-0]|TX|4624/8;2253/8;679/8|
00000000|MMI|9.02|Possibly Related to Intervention|C1705910|[qlco]|["Possible"-tx-27-"possible"-adj-0,"Possible"-tx-9-"POSSIBLE"-adj-0,"Possible"-tx-4-"POSSIBLE"-adj-0]|TX|4624/8;2253/8;679/8|
00000000|MMI|9.02|Approximate|C0332232|[qlco]|["Approximate"-tx-8-"approximate"-adj-0,"Approximate"-tx-7-"approximate"-adj-0]|TX|1833/11;1487/11|
00000000|MMI|9.02|Diagnosis Study|C1704656|[resa]|["DIAGNOSIS"-tx-11-"DIAGNOSIS"-noun-0]|TX|[2684/9],[2806/9]|
00000000|MMI|9.02|Hold (action)|C1948035|[acty]|["Hold"-tx-7-"HOLD"-verb-0,"Hold"-tx-4-"HOLD"-verb-0]|TX|1298/4;455/4|
00000000|MMI|9.02|Hold - dosing instruction fragment|C1553387|[idcn]|["Hold"-tx-7-"HOLD"-verb-0,"Hold"-tx-4-"HOLD"-verb-0]|TX|1298/4;455/4|
00000000|MMI|9.02|Requirement|C1514873|[ftcn]|["Required"-tx-8-"Required"-verb-0,"Required"-tx-7-"Required"-verb-0]|TX|1822/8;1476/8|
00000000|MMI|9.02|VIT gene|C1421454|[gngm]|["VIT"-tx-8-"VIT"-noun-0,"VIT"-tx-5-"VIT"-noun-0]|TX|1983/3;1079/3|
00000000|MMI|9.02|Vitamin B3 Assay|C1142562|[lbpr]|["Niacin"-tx-8-"NIACIN"-noun-0,"Niacin"-tx-5-"NIACIN"-noun-0]|TX|1974/6;1070/6|
00000000|MMI|9.02|hold - Data Operation|C3853841|[ftcn]|["hold"-tx-7-"HOLD"-verb-0,"hold"-tx-4-"HOLD"-verb-0]|TX|1298/4;455/4|
00000000|MMI|9.02|orders - HL7PublishingDomain|C3244315|[inpr]|["orders"-tx-52-"ORDERS"-verb-0,"orders"-tx-1-"ORDERS"-verb-0]|TX|5931/6;49/6|
00000000|MMI|9.02|sulfa|C0749139|[phsu]|["sulfa"-tx-28-"sulfa"-noun-0,"sulfa"-tx-11-"Sulfa"-noun-0]|TX|4753/5;2656/5|
00000000|MMI|8.61|Appointments|C0003629|[idcn]|["Appointment"-tx-10-"APPOINTMENT"-noun-0]|TX|2583/11|N04.452.095
00000000|MMI|8.54|Chills|C0085593|[sosy]|["CHILLS"-tx-18-"chills"-noun-0]|TX|3815/6|C23.888.208
00000000|MMI|8.53|Body position|C1262869|[orga]|["POS"-tx-18-"pos"-noun-0]|TX|3717/3|G11.427.695
00000000|MMI|8.53|Assisted Reproductive Technologies|C0872104|[topp]|["IVF"-tx-37-"IVFs"-noun-0]|TX|5242/4|E02.875.800;E05.820.800
00000000|MMI|8.45|Food|C0016452|[food]|["Food"-tx-7-"food"-noun-0]|TX|1410/4|G07.203.300;J02.500
00000000|MMI|8.44|Kidney|C0022646|[bpoc]|["Renal"-tx-34-"renal"-adj-0]|TX|5037/5|A05.810.453
00000000|MMI|7.22|Allergic Reaction|C1527304|[patf]|["Allergy"-tx-11-"ALLERGY"-noun-0]|TX|2637/7|C20.543
00000000|MMI|7.22|Hypersensitivity|C0020517|[patf]|["ALLERGY"-tx-11-"ALLERGY"-noun-0]|TX|2637/7|C20.543
00000000|MMI|7.22|Infection|C3714514|[patf]|["Infections"-tx-11-"Infections"-noun-0]|TX|2829/10|C01.539
00000000|MMI|7.22|Measures|C0079809|[qnco]|["Measure"-tx-10-"measure"-verb-0]|TX|2434/7|E05.978
00000000|MMI|6.83|4 Hours|C1292426|[tmco]|["4 Hours"-tx-43-"4 hours"-noun-0,"4 Hours"-tx-26-"4 hours"-noun-0]|TX|5434/1,5438/5;4531/7|
00000000|MMI|6.58|Condition|C0348080|[qlco]|["Condition"-tx-47-"CONDITION"-noun-0,"Condition"-tx-11-"Conditions"-noun-0]|TX|5645/9;2816/10|
00000000|MMI|6.58|Condition:Find:Pt:^Patient:Nom|C3864998|[clna]|["Condition"-tx-47-"CONDITION"-noun-0,"Condition"-tx-11-"Conditions"-noun-0]|TX|5645/9;2816/10|
00000000|MMI|6.58|Logical Condition|C1705253|[cnce]|["Condition"-tx-47-"CONDITION"-noun-0,"Condition"-tx-11-"Conditions"-noun-0]|TX|5645/9;2816/10|
00000000|MMI|6.51|Admission Level of Care Code - Improved|C1561611|[inpr]|["Improved"-tx-37-"improved"-verb-0,"Improved"-tx-32-"improved"-verb-0]|TX|5214/8;4953/8|
00000000|MMI|6.51|Better|C0332272|[qlco]|["Improved"-tx-37-"improved"-verb-0,"Improved"-tx-32-"improved"-verb-0]|TX|5214/8;4953/8|
00000000|MMI|6.51|Improved|C0184511|[qlco]|["Improved"-tx-37-"improved"-verb-0,"Improved"-tx-32-"improved"-verb-0]|TX|5214/8;4953/8|
00000000|MMI|6.51|Symptoms|C1457887|[sosy]|["SYMPTOMS"-tx-32-"symptoms"-noun-0,"SYMPTOMS"-tx-14-"symptoms"-noun-0]|TX|4935/8;3491/8|
00000000|MMI|6.51|Symptoms aspect|C0683368|[ftcn]|["symptoms"-tx-32-"symptoms"-noun-0,"symptoms"-tx-14-"symptoms"-noun-0]|TX|4935/8;3491/8|
00000000|MMI|6.48|Biomedical Monitors|C0181904|[medd]|["Monitor"-tx-29-"monitor"-noun-0,"Monitor"-tx-10-"monitor"-verb-0]|TX|4786/7;2368/7|
00000000|MMI|6.48|Monitor Device Component|C1704646|[mnob]|["Monitor"-tx-29-"monitor"-noun-0,"Monitor"-tx-10-"monitor"-verb-0]|TX|4786/7;2368/7|
00000000|MMI|6.48|Monitor, occupation|C1521743|[prog]|["Monitor"-tx-29-"monitor"-noun-0,"Monitor"-tx-10-"monitor"-verb-0]|TX|4786/7;2368/7|
00000000|MMI|6.48|Monitoring Device|C0596972|[medd]|["Monitor"-tx-29-"monitor"-noun-0,"Monitor"-tx-10-"monitor"-verb-0]|TX|4786/7;2368/7|
00000000|MMI|6.46|Give - dosing instruction imperative|C1947971|[ftcn]|["Give"-tx-7-"Give"-verb-0,"Give"-tx-7-"give"-verb-0]|TX|1354/4;1381/4|
00000000|MMI|6.45|Started|C1272689|[qlco]|["Started"-tx-16-"started"-verb-0,"Started"-tx-12-"started"-verb-0]|TX|3618/7;3278/7|
00000000|MMI|6.37|Call (Instruction)|C1947967|[ftcn]|["Call"-tx-45-"call"-noun-0,"Call"-tx-29-"call"-verb-0]|TX|5603/4;4807/4|
00000000|MMI|6.37|Decision|C0679006|[menp]|["Call"-tx-45-"call"-noun-0,"Call"-tx-29-"call"-verb-0]|TX|5603/4;4807/4|
00000000|MMI|6.37|Therapeutic|C0302350|[ftcn]|["Therapeutic"-tx-5-"THERAPEUTIC"-adj-0]|TX|[863/11],[877/11]|E02
00000000|MMI|6.37|Therapeutic procedure|C0087111|[topp]|["Therapeutic"-tx-5-"THERAPEUTIC"-adj-0]|TX|[863/11],[877/11]|E02
00000000|MMI|6.32|Interaction|C1704675|[ftcn]|["Interaction"-tx-8-"INTERACTION"-noun-0,"Interaction"-tx-5-"INTERACTION"-noun-0]|TX|1961/11;1057/11|
00000000|MMI|6.32|Services|C0557854|[ocac]|["Services"-tx-30-"services"-noun-0,"Service"-tx-1-"Service"-noun-0]|TX|4864/8;105/7|
00000000|MMI|6.32|Medical Examination|C0582103|[hlca]|["Exam"-tx-33-"exam"-noun-0,"Exam"-tx-19-"Exam"-noun-0]|TX|5003/4;3863/4|
00000000|MMI|6.31|60%|C3842585|[fndg]|["60%"-tx-14-"60"-integer-0,"60%"-tx-7-"60"-integer-0]|TX|3509/2;1283/2|
00000000|MMI|6.30|Prothrombin Activity Measurement|C3274435|[lbpr]|["PTA"-tx-17-"pta"-noun-0,"PTA"-tx-16-"pta"-noun-0]|TX|3708/3;3640/3|
00000000|MMI|6.28|Summary (document)|C1706244|[inpr]|["Summary"-tx-49-"summary"-noun-0,"Summary"-tx-1-"SUMMARY"-noun-0]|TX|5825/7;224/7|
00000000|MMI|6.28|summary - ActRelationshipSubset|C1552616|[inpr]|["summary"-tx-49-"summary"-noun-0,"summary"-tx-1-"SUMMARY"-noun-0]|TX|5825/7;224/7|
00000000|MMI|6.28|Hospital course|C0489547|[fndg]|["Hospital course"-tx-23-"Hospital Course"-noun-0,"Hospital course"-tx-11-"HOSPITAL COURSE"-noun-1]|TX|4304/15;3140/15|
00000000|MMI|6.28|Hospital course:Finding:Point in time:^Patient:Narrative|C0488549|[clna]|["Hospital course"-tx-23-"Hospital Course"-noun-0,"Hospital course"-tx-11-"HOSPITAL COURSE"-noun-0]|TX|4304/15;3140/15|
00000000|MMI|6.25|Dose number|C1115464|[qnco]|["Dose number"-tx-8-"Number Doses"-noun-0,"Dose number"-tx-7-"Number Doses"-noun-0]|TX|1806/6,1816/5;1460/6,1470/5|
00000000|MMI|6.24|4+ Answer to question|C3838679|[fndg]|["4+"-tx-52-"4"-fraction-0,"4+"-tx-1-"4"-fraction-0]|TX|5889/1;140/1|
00000000|MMI|6.15|((5,6-dichloro-2,3,9,9a-tetrahydro-3-oxo-9a-propyl-1H-fluoren-7-yl)oxy)acetic acid|C0378071|[orch,phsu]|["b-3"-tx-9-"B-3"-adj-0,"b-3"-tx-6-"B-3"-adj-0]|TX|1988/3;1084/3|
00000000|MMI|6.15|Infusion pump Alert priority PM|C4049155|[fndg]|["PM"-tx-52-"PM"-noun-0,"PM"-tx-1-"PM"-adj-0]|TX|5904/2;156/2|
00000000|MMI|6.15|Weekly|C0332174|[tmco]|["/week"-tx-49-"week"-noun-0,"/week"-tx-14-"week"-noun-0]|TX|5777/4;3420/4|
00000000|MMI|6.15|R prime|C2603358|[clna]|["R'"-tx-16-"R"-noun-0,"R'"-tx-11-"R"-noun-0]|TX|3594/1;3108/1|
00000000|MMI|6.15|Right|C0205090|[spco]|["R-"-tx-16-"R"-noun-0,"R-"-tx-11-"R"-noun-0]|TX|3594/1;3108/1|
00000000|MMI|6.08|Increased|C0205217|[qnco]|["Increased"-tx-25-"increased"-verb-0,"Increased"-tx-22-"increased"-adj-0]|TX|4441/9;4266/9|
00000000|MMI|6.08|Dosage|C0178602|[qnco]|["DOSE"-tx-34-"dose"-noun-0,"DOSE"-tx-14-"dose"-noun-0]|TX|5043/4;3368/4|
00000000|MMI|6.08|Unit dose|C0869039|[qnco]|["Dose"-tx-34-"dose"-noun-0,"Dose"-tx-14-"dose"-noun-0]|TX|5043/4;3368/4|
00000000|MMI|6.08|Probable diagnosis|C0332148|[qlco]|["Likely"-tx-21-"likely"-adv-0,"Probable"-tx-7-"PROBABLE"-adj-0]|TX|4185/6;1717/8|
00000000|MMI|6.07|Code|C0805701|[inpr]|["CODE"-tx-4-"CODE"-noun-0,"CODE"-tx-4-"code"-noun-0]|TX|289/4;307/4|
00000000|MMI|6.07|eTMF Content Model Code|C3889831|[inpr]|["Code"-tx-4-"CODE"-noun-0,"Code"-tx-4-"code"-noun-0]|TX|289/4;307/4|
00000000|MMI|6.05|Serious|C0205404|[qlco]|["Serious"-tx-8-"SERIOUS"-adj-0,"Serious"-tx-5-"SERIOUS"-adj-0]|TX|1953/7;1049/7|
00000000|MMI|6.03|Tablet Dosing Unit|C1705223|[qnco]|["Tab"-tx-7-"TAB"-noun-0,"Tab"-tx-5-"TAB"-noun-0]|TX|1561/3;904/3|
00000000|MMI|6.01|House (environment)|C2003847|[mnob]|["House"-tx-10-"House"-noun-0]|TX|[2461/5],[2497/5]|
00000000|MMI|5.99|80%|C3842583|[fndg]|["80%"-tx-39-"80"-integer-0,"80%"-tx-4-"80"-integer-0]|TX|5271/2;539/2|
00000000|MMI|5.99|Only - dosing instruction fragment|C1720467|[inpr]|["Only"-tx-18-"only"-adv-0,"Only"-tx-16-"only"-adv-0]|TX|3721/4;3539/4|
00000000|MMI|5.99|Singular|C0205171|[qnco]|["Only"-tx-18-"only"-adv-0,"Only"-tx-16-"only"-adv-0]|TX|3721/4;3539/4|
00000000|MMI|5.82|Body Fluids|C0005889|[bdsu]|["FLUID"-tx-18-"fluid"-noun-0]|TX|3785/5|A12.207
00000000|MMI|5.73|Health|C0018684|[idcn]|["Health"-tx-16-"health"-noun-0]|TX|3551/6|N01.400
00000000|MMI|4.49|+5|C0728893|[qnco]|["+5"-tx-38-"5"-integer-0]|TX|5248/1|
00000000|MMI|4.49|3+ Answer to Question|C3838680|[fndg]|["3+"-tx-35-"3"-integer-0]|TX|5082/1|
00000000|MMI|4.49|3+ Score|C2827736|[qnco]|["3+"-tx-35-"3"-integer-0]|TX|5082/1|
00000000|MMI|4.49|3+ Score, WHO|C2981702|[clas]|["3+"-tx-35-"3"-integer-0]|TX|5082/1|
00000000|MMI|4.49|<3 (qualifier value)|C0439086|[qnco]|["<3"-tx-35-"3"-integer-0]|TX|5082/1|
00000000|MMI|4.49|>5|C0439084|[qnco]|[">5"-tx-38-"5"-integer-0]|TX|5248/1|
00000000|MMI|4.49|ABD tumor staging notation|C0449202|[inpr]|["ABD"-tx-20-"abd"-noun-0]|TX|3998/3|
00000000|MMI|4.49|Absence of Biallelic TCRgamma Deletion|C3811055|[comd]|["ABD"-tx-20-"abd"-noun-0]|TX|3998/3|
00000000|MMI|4.49|Affecting|C0392760|[ftcn]|["Affecting"-tx-11-"affecting"-verb-0]|TX|2858/9|
00000000|MMI|4.49|Allergic disposition|C3539909|[dsyn]|["Allergy"-tx-11-"ALLERGY"-noun-0]|TX|2637/7|
00000000|MMI|4.49|Allergy - Physicians|C1554743|[prog]|["Allergy"-tx-11-"ALLERGY"-noun-0]|TX|2637/7|
00000000|MMI|4.49|As Needed|C1883728|[qlco]|["As Needed"-tx-49-"as needed"-adj-0]|TX|5803/9|
00000000|MMI|4.49|Blood glucose measurement|C0392201|[lbpr]|["Blood Sugar"-tx-43-"blood sugar"-noun-0]|TX|5416/11|
00000000|MMI|4.49|CALD1 wt Allele|C3813548|[gngm]|["CAD"-tx-12-"CAD"-noun-0]|TX|3227/3|
00000000|MMI|4.49|Clinical Trial Final Report|C3889645|[inpr]|["Reports"-tx-32-"reports"-verb-0]|TX|4927/7|
00000000|MMI|4.49|Clinical Trials, Monitoring|C1516647|[resa]|["monitoring"-tx-48-"monitoring"-verb-0]|TX|5723/10|
00000000|MMI|4.49|Complication|C0009566|[patf]|["Complications"-tx-11-"Complications"-noun-0]|TX|2842/13|
00000000|MMI|4.49|Contain (action)|C2700400|[acty]|["Containing"-tx-28-"containing"-verb-0]|TX|4759/10|
00000000|MMI|4.49|Containing (qualifier)|C0332256|[ftcn]|["Containing"-tx-28-"containing"-verb-0]|TX|4759/10|
00000000|MMI|4.49|Continuous|C0549178|[idcn]|["Continue"-tx-34-"continue"-verb-0]|TX|5014/8|
00000000|MMI|4.49|Cut in Medical Device Material|C1883724|[phpr]|["Cut"-tx-14-"cut"-verb-0]|TX|3360/3|
00000000|MMI|4.49|Deterioration of status|C1279889|[fndg]|["Worse"-tx-22-"worse"-adj-0]|TX|4297/5|
00000000|MMI|4.49|Discharge date|C2361123|[tmco]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|4.49|Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2361122|[clna]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|4.49|Doctor of Philosophy|C1512022|[inpr]|["Ph.D."-tx-51-"PH.D"-noun-0]|TX|5874/4|
00000000|MMI|4.49|Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider}|C1316572|[clna]|["Note"-tx-27-"Note"-noun-0]|TX|4609/4|
00000000|MMI|4.49|Finger-prick sampling (procedure)|C0457575|[diap]|["finger sticks"-tx-25-"Finger sticks"-noun-0]|TX|4390/13|
00000000|MMI|4.49|GRAPEFRUIT EXTRACT|C0440280|[orch,phsu]|["GRAPEFRUIT"-tx-6-"grapefruit"-noun-0]|TX|1198/10|
00000000|MMI|4.49|Grapefruit (food)|C0995150|[food]|["GRAPEFRUIT"-tx-6-"grapefruit"-noun-0]|TX|1198/10|
00000000|MMI|4.49|Grapefruit Flavor|C1365950|[food]|["GRAPEFRUIT"-tx-6-"grapefruit"-noun-0]|TX|1198/10|
00000000|MMI|4.49|Incised wound|C0000925|[inpo]|["Cut"-tx-14-"cut"-verb-0]|TX|3360/3|
00000000|MMI|4.49|Interventional procedure|C0184661|[topp]|["PROCEDURES"-tx-11-"PROCEDURES"-noun-0]|TX|3052/10|
00000000|MMI|4.49|Involvement with|C1314939|[ftcn]|["Affecting"-tx-11-"affecting"-verb-0]|TX|2858/9|
00000000|MMI|4.49|MYOTONIC DYSTROPHY 1|C3250443|[dsyn]|["DM"-tx-12-"DM"-noun-0]|TX|3222/2|
00000000|MMI|4.49|Measurement|C0242485|[ftcn]|["Measure"-tx-10-"measure"-verb-0]|TX|2434/7|
00000000|MMI|4.49|Medications:-:Point in time:^Patient:-|C2598133|[clna]|["Medications"-tx-4-"MEDICATIONS"-noun-0]|TX|352/11|
00000000|MMI|4.49|Medications:Presence or Identity:Duration of the study:^Patient:Nominal|C0802604|[clna]|["Medications"-tx-4-"MEDICATIONS"-noun-0]|TX|352/11|
00000000|MMI|4.49|Metformin hydrochloride|C0770893|[orch,phsu]|["Metformin HCl"-tx-11-"METFORMIN HCL"-noun-0]|TX|2664/13|
00000000|MMI|4.49|Monitoring - action|C1283169|[hlca]|["Monitoring"-tx-48-"monitoring"-verb-0]|TX|5723/10|
00000000|MMI|4.49|Most|C0205393|[qnco]|["Much"-tx-32-"much"-adv-0]|TX|4948/4|
00000000|MMI|4.49|Negative - answer|C3853545|[qlco]|["NEG"-tx-21-"neg"-noun-0]|TX|4131/3|
00000000|MMI|4.49|Normal diet|C0184625|[dora]|["Normal diet"-tx-26-"normal diet"-noun-0]|TX|4492/11|
00000000|MMI|4.49|Not Applicable|C1272460|[qlco]|["NOT APPLICABLE"-tx-1-"Not Applicable"-adj-0]|TX|175/14|
00000000|MMI|4.49|Note (document)|C1317574|[inpr]|["Note"-tx-27-"Note"-noun-0]|TX|4609/4|
00000000|MMI|4.49|Obesity Adverse Event|C1963185|[fndg]|["Obesity"-tx-11-"obesity"-noun-0]|TX|3003/7|
00000000|MMI|4.49|PRN (schedule frequency)|C1879745|[tmco]|["As needed"-tx-49-"as needed"-adj-0]|TX|5803/9|
00000000|MMI|4.49|Package Type Not Applicable|C4049872|[ftcn]|["Not Applicable"-tx-1-"Not Applicable"-adj-0]|TX|175/14|
00000000|MMI|4.49|Pharmaceutical Preparations|C0013227|[phsu]|["Medications"-tx-4-"MEDICATIONS"-noun-0]|TX|352/11|D26
00000000|MMI|4.49|Procedure (set of actions)|C2700391|[acty]|["Procedures"-tx-11-"PROCEDURES"-noun-0]|TX|3052/10|
00000000|MMI|4.49|Regulatory Report|C3273238|[inpr]|["Report"-tx-32-"reports"-verb-0]|TX|4927/7|
00000000|MMI|4.49|Renal function|C0232804|[ortf]|["Renal function"-tx-49-"renal function"-noun-0]|TX|5745/14|
00000000|MMI|4.49|Report (document)|C0684224|[inpr]|["Reports"-tx-32-"reports"-verb-0]|TX|4927/7|
00000000|MMI|4.49|Reporting|C0700287|[hlca]|["reports"-tx-32-"reports"-verb-0]|TX|4927/7|
00000000|MMI|4.49|Response to antigens|C1314973|[phsf]|["ALLERGY"-tx-11-"ALLERGY"-noun-0]|TX|2637/7|
00000000|MMI|4.49|S prime|C2603362|[clna]|["S'"-tx-10-"("-noun-0]|TX|2594/1|
00000000|MMI|4.49|Schedule (document type)|C0086960|[inpr]|["Scheduled"-tx-11-"scheduled"-verb-0]|TX|2625/9|
00000000|MMI|4.49|Scheduled - priority|C1571999|[qlco]|["Scheduled"-tx-11-"scheduled"-verb-0]|TX|2625/9|
00000000|MMI|4.49|Scheduled - procedure status|C0205539|[qlco]|["Scheduled"-tx-11-"scheduled"-verb-0]|TX|2625/9|
00000000|MMI|4.49|Sugars|C0242209|[orch,phsu]|["Sugars"-tx-26-"sugars"-noun-0]|TX|4518/6|D09
00000000|MMI|4.49|Unlikely|C0750558|[cnce]|["Unlikely"-tx-28-"Unlikely"-adj-0]|TX|4710/8|
00000000|MMI|4.49|Unlikely Related to Intervention|C1710571|[qlco]|["Unlikely"-tx-28-"Unlikely"-adj-0]|TX|4710/8|
00000000|MMI|4.49|Worse|C1457868|[fndg]|["Worse"-tx-22-"worse"-adj-0]|TX|4297/5|
00000000|MMI|4.49|Worsening pattern|C0332271|[qlco]|["worse"-tx-22-"worse"-adj-0]|TX|4297/5|
00000000|MMI|4.49|aspirin enteric coated|C0718690|[orch,phsu]|["enteric coated aspirin"-tx-4-"ENTERIC COATED ASPIRIN"-noun-0]|TX|365/22|
00000000|MMI|4.49|atorvastatin|C0286651|[orch,phsu]|["ATORVASTATIN"-tx-8-"ATORVASTATIN"-noun-0]|TX|1863/12|
00000000|MMI|4.49|per second|C0565930|[qnco]|["/s"-tx-10-"("-noun-0]|TX|2594/1|
00000000|MMI|4.49|treatments and procedures|C0237403|[topp]|["treatments procedures"-tx-11-"TREATMENTS/PROCEDURES"-noun-0]|TX|3075/21|
00000000|MMI|3.44|Make - Instruction Imperative|C1881534|[ftcn]|["Make"-tx-22-"made"-verb-0]|TX|4287/4|
00000000|MMI|3.30|Operative procedure on coronary artery|C0190188|[topp]|["Coronary artery operations NOS"-tx-11-"coronary artery OPERATIONS"-noun-0]|TX|3013/15,3037/10|
00000000|MMI|3.28|On treatment for hypertension|C0578998|[hlca]|["treatment hypertension"-tx-11-"Treatment hypertension"-noun-0]|TX|2868/9,2883/12|
00000000|MMI|3.25|Additional comments|C1830770|[fndg]|["Additional comments"-tx-43-"ADDITIONAL COMMENTS"-noun-1]|TX|5384/19|
00000000|MMI|3.25|SLC33A1 gene|C1412113|[gngm]|["AT-1"-tx-37-"at 1"-noun-0]|TX|5198/4|
00000000|MMI|3.22|Greater Than|C0439093|[qnco]|["Greater Than"-tx-43-"greater than"-adj-0]|TX|5461/12|
00000000|MMI|3.21|Principal Diagnosis:-:Point in time:^Patient:-|C2598194|[clna]|["Principal Diagnosis"-tx-11-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|2708/9,2728/9|
00000000|MMI|3.21|Principal diagnosis|C0332137|[qlco]|["Principal Diagnosis"-tx-11-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|2708/9,2728/9|
00000000|MMI|3.19|Daily MULTIVITAMINS|C0719642|[orch,phsu,vita]|["Daily Multivitamin"-tx-5-"DAILY MULTIVITAMIN"-noun-0]|TX|810/5,850/12|
00000000|MMI|3.19|68|C0450387|[inpr]|["68"-tx-21-"68"-integer-0]|TX|4111/2|
00000000|MMI|3.19|Attending (action)|C1999232|[ftcn]|["attending"-tx-1-"Attending"-noun-0]|TX|237/9|
00000000|MMI|3.19|Attending (provider role)|C1547429|[prog]|["Attending"-tx-1-"Attending"-noun-0]|TX|237/9|
00000000|MMI|3.19|Axial R|C3538806|[spco]|["Ra"-tx-19-"ra"-noun-0]|TX|3891/2|
00000000|MMI|3.19|Cardiologist|C0175906|[prog]|["Cardiologist"-tx-40-"cardiologist"-noun-0]|TX|5301/12|
00000000|MMI|3.19|Coating (film)|C1522408|[qlco]|["Coated"-tx-4-"COATED"-adj-0]|TX|406/6|
00000000|MMI|3.19|Enteral|C1304890|[spco]|["Enteric"-tx-4-"ENTERIC"-adj-0]|TX|398/7|
00000000|MMI|3.19|Entire ankle region|C1283839|[blor]|["Ankle"-tx-16-"ankle"-noun-0]|TX|3596/5|
00000000|MMI|3.19|Good|C0205170|[qlco]|["Well"-tx-20-"well"-adj-0]|TX|3901/4|
00000000|MMI|3.19|Hour|C0439227|[tmco]|["HOURS"-tx-25-"hours"-noun-0]|TX|4426/5|
00000000|MMI|3.19|Laboratory test finding|C0587081|[fndg]|["Labs"-tx-21-"Labs"-noun-0]|TX|4121/4|
00000000|MMI|3.19|NADPH:sulfur oxidoreductase activity|C2700623|[moft]|["NSR"-tx-21-"NSR"-noun-0]|TX|4107/3|
00000000|MMI|3.19|Neutral Sidebent Rotated|C1704493|[patf]|["NSR"-tx-21-"NSR"-noun-0]|TX|4107/3|
00000000|MMI|3.19|Respiratory Domain|C2986904|[idcn]|["RE"-tx-14-"re"-noun-0]|TX|3343/2|
00000000|MMI|3.19|Retinol equivalents|C0556581|[qnco]|["{RE}"-tx-14-"re"-noun-0]|TX|3343/2|
00000000|MMI|3.19|Right arm|C4048756|[bpoc]|["RA"-tx-19-"ra"-noun-0]|TX|3891/2|
00000000|MMI|3.19|Status|C0449438|[qlco]|["Status"-tx-4-"STATUS"-noun-0]|TX|294/6|
00000000|MMI|3.19|Well|C3146287|[mnob]|["Well"-tx-20-"well"-adj-0]|TX|3901/4|
00000000|MMI|3.19|discharge diagnosis|C1555319|[fndg]|["Discharge diagnosis"-tx-11-"DISCHARGE DIAGNOSIS"-noun-0]|TX|2718/19|
00000000|MMI|3.15|Entered|C1521975|[qlco]|["Entered"-tx-49-"ENTERED"-verb-0]|TX|5833/7|
00000000|MMI|3.15|Renal clearance diagnostic test|C0699829|[diap]|["Renal Clearance"-tx-21-"renal clearance"-noun-0]|TX|4204/15|
00000000|MMI|3.15|Renal clearance function|C0232813|[ortf]|["Renal clearance"-tx-21-"renal clearance"-noun-0]|TX|4204/15|
00000000|MMI|3.15|Appearance|C0700364|[qlco]|["APPEAR"-tx-20-"appearing"-adj-0]|TX|3906/9|
00000000|MMI|3.15|Creatinine finding|C1561535|[fndg]|["Creatinine"-tx-37-"creatinine"-noun-0]|TX|5178/10|
00000000|MMI|3.15|Disposition|C0743223|[idcn]|["Disposition"-tx-4-"DISPOSITION"-noun-0]|TX|312/11|
00000000|MMI|3.15|Disposition Domain|C1705555|[inpr]|["Disposition"-tx-4-"DISPOSITION"-noun-0]|TX|312/11|
00000000|MMI|3.15|Pixels per Inch|C3811894|[idcn]|["PPI"-tx-43-"PPI"-noun-0]|TX|5368/3|
00000000|MMI|3.15|Reactive Oxygen Metabolite Measurement|C4048784|[lbpr]|["ROM"-tx-20-"ROM"-noun-0]|TX|4097/3|
00000000|MMI|3.13|*Activity (kind of quantity)|C1561536|[idcn]|["*Activity"-tx-10-"ACTIVITY"-noun-0]|TX|2542/8|
00000000|MMI|3.13|ActInformationPrivacyReason <operations>|C3244305|[ftcn]|["operations"-tx-11-"OPERATIONS"-noun-0]|TX|3037/10|
00000000|MMI|3.13|Active|C0205177|[ftcn]|["Activity"-tx-10-"ACTIVITY"-noun-0]|TX|2542/8|
00000000|MMI|3.13|Activities|C0441655|[acty]|["ACTIVITY"-tx-10-"ACTIVITY"-noun-0]|TX|2542/8|
00000000|MMI|3.13|Activity (animal life circumstance)|C3668946|[fndg]|["Activity"-tx-10-"ACTIVITY"-noun-0]|TX|2542/8|
00000000|MMI|3.13|Changed status|C0443172|[qnco]|["change"-tx-16-"change"-noun-0]|TX|3558/6|
00000000|MMI|3.13|Changing|C0392747|[ftcn]|["Change"-tx-16-"change"-noun-0]|TX|3558/6|
00000000|MMI|3.13|Delta (difference)|C1705241|[qnco]|["Change"-tx-16-"change"-noun-0]|TX|3558/6|
00000000|MMI|3.13|FDA Establishment Activity Terminology|C4049939|[inpr]|["ACTIVITY"-tx-10-"ACTIVITY"-noun-0]|TX|2542/8|
00000000|MMI|3.13|HL7PublishingSubSection <operations>|C3244306|[inpr]|["operations"-tx-11-"OPERATIONS"-noun-0]|TX|3037/10|
00000000|MMI|3.13|Percent Activity|C0439167|[qnco]|["% Activity"-tx-10-"ACTIVITY"-noun-0]|TX|2542/8|
00000000|MMI|3.13|Physical Activity Measurement|C4049938|[lbpr]|["ACTIVITY"-tx-10-"ACTIVITY"-noun-0]|TX|2542/8|
00000000|MMI|3.13|Planned|C1301732|[ftcn]|["Plan"-tx-47-"PLAN"-noun-0]|TX|5669/4|
00000000|MMI|3.13|Treatment Plan|C0599880|[inpr]|["Plan"-tx-47-"PLAN"-noun-0]|TX|5669/4|
00000000|MMI|3.12|New Diagnosis Procedure|C1882082|[diap]|["New Diagnosis"-tx-16-"new diagnosis"-noun-0]|TX|3570/13|
00000000|MMI|3.12|New diagnosis (finding)|C2585997|[fndg]|["New diagnosis"-tx-16-"new diagnosis"-noun-0]|TX|3570/13|
00000000|MMI|3.12|TDGF1P4 gene|C3469969|[gngm]|["CR-4"-tx-21-"cr 4"-noun-0]|TX|4137/2,4142/1|
00000000|MMI|3.11|ActInformationPrivacyReason <service>|C3245478|[idcn]|["service"-tx-1-"Service"-noun-0]|TX|105/7|
00000000|MMI|3.11|Software Service|C2825316|[mnob]|["Service"-tx-1-"Service"-noun-0]|TX|105/7|
00000000|MMI|3.11|70%|C3842584|[fndg]|["70%"-tx-14-"70"-integer-0]|TX|3483/2|
00000000|MMI|3.11|Base - General Qualifier|C1705938|[idcn]|["Based"-tx-33-"based"-verb-0]|TX|4994/5|
00000000|MMI|3.11|Basis - conceptual entity|C1527178|[ftcn]|["Based"-tx-33-"based"-verb-0]|TX|4994/5|
00000000|MMI|3.11|End|C0444930|[spco]|["End"-tx-52-"END"-noun-0]|TX|5914/3|
00000000|MMI|3.11|Low dose|C0445550|[qnco]|["Low dose"-tx-24-"low dose"-noun-0]|TX|4371/8|
00000000|MMI|3.11|Low-Dose Treatment|C1708745|[resa]|["Low-Dose"-tx-24-"low dose"-noun-0]|TX|4371/8|
00000000|MMI|3.11|Responsible to|C1273518|[fndg]|["Responsible"-tx-11-"Responsible"-adj-0]|TX|2739/11|
00000000|MMI|3.11|Stop (qualifier value)|C2746065|[tmco]|["End"-tx-52-"END"-noun-0]|TX|5914/3|
00000000|MMI|3.11|Treated with|C0332293|[topp]|["Treated with"-tx-24-"treated with"-verb-0]|TX|4358/12|
00000000|MMI|3.11|Instructions:Text:Point in time:^Patient:Narrative|C3263700|[clna]|["Instructions"-tx-9-"Instructions"-noun-0]|TX|2094/12|
00000000|MMI|3.10|opioid use|C0240602|[mobd]|["NARCOTIC USE"-tx-34-"use narcotics"-noun-0]|TX|5052/13|
00000000|MMI|3.09|Colchicine 0.6 MG|C0985108|[clnd]|["Colchicine 0.6 MG"-tx-10-"COLCHICINE 0.6 MG"-noun-0]|TX|2376/17|
00000000|MMI|3.09|Conditional|C1701901|[qlco]|["Contingent"-tx-1-"CONTINGENT"-noun-0]|TX|159/10|
00000000|MMI|3.09|Endocrine System Findings Domain|C3538926|[idcn]|["ED"-tx-46-"ED"-noun-0]|TX|5631/2|
00000000|MMI|3.09|Fluid behavior|C0444611|[qlco]|["Fluid"-tx-18-"fluid"-noun-0]|TX|3785/5|
00000000|MMI|3.09|GORAB gene|C1822658|[gngm]|["GO"-tx-46-"go"-verb-0]|TX|5621/2|
00000000|MMI|3.09|Liquid substance|C0302908|[sbst]|["fluid"-tx-18-"fluid"-noun-0]|TX|3785/5|
00000000|MMI|3.09|Manifest|C0205319|[ftcn]|["Manifest"-tx-27-"manifest"-verb-0]|TX|4656/8|
00000000|MMI|3.09|Negation|C1518422|[ftcn]|["Not"-tx-11-"NOT"-adv-0]|TX|3099/3|
00000000|MMI|3.09|Probably|C0750492|[idcn]|["Likely"-tx-21-"likely"-adv-0]|TX|4185/6|
00000000|MMI|3.09|cmH2O|C0439476|[qnco]|["cm H2O"-tx-20-"cm H2O"-noun-0]|TX|3933/6|
00000000|MMI|3.09|fluid - substance|C1704353|[sbst]|["Fluid"-tx-18-"fluid"-noun-0]|TX|3785/5|
00000000|MMI|3.08|Baseline|C1442488|[qnco]|["Baseline"-tx-21-"baseline"-noun-0]|TX|4147/8|
00000000|MMI|3.08|Concern|C2699424|[idcn]|["Concern"-tx-33-"concern"-noun-0]|TX|4966/7|
00000000|MMI|3.08|Entire stomach|C1278920|[bpoc]|["Stomach"-tx-7-"stomach"-noun-0]|TX|1371/7|
00000000|MMI|3.08|Gastric Tissue|C1517454|[tisu]|["STOMACH"-tx-7-"stomach"-noun-0]|TX|1371/7|
00000000|MMI|3.08|Radiography Study File|C3891450|[inpr]|["RAD"-tx-20-"rad"-noun-0]|TX|3984/3|
00000000|MMI|3.08|Stomach structure|C3714551|[bpoc]|["Stomach"-tx-7-"stomach"-noun-0]|TX|1371/7|
00000000|MMI|3.08|ribosome-associated ubiquitin-dependent protein catabolic process|C3811628|[celf]|["RAD"-tx-20-"rad"-noun-0]|TX|3984/3|
00000000|MMI|3.08|Add - instruction imperative|C1883712|[ftcn]|["Addition"-tx-22-"addition"-noun-0]|TX|4243/8|
00000000|MMI|3.08|In addition to|C0332287|[ftcn]|["Addition"-tx-22-"addition"-noun-0]|TX|4243/8|
00000000|MMI|3.08|MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME|C3280240|[dsyn]|["MEDS"-tx-36-"meds"-noun-0]|TX|5101/4|
00000000|MMI|3.08|Used by|C1273517|[fndg]|["used"-tx-1-"USED"-verb-1]|TX|208/4|
00000000|MMI|3.07|ERF gene|C1333360|[gngm]|["PE-2"-tx-20-"2 PE"-noun-0]|TX|4021/1,4037/2|
00000000|MMI|3.07|ERF wt Allele|C1707867|[gngm]|["PE-2"-tx-20-"2 PE"-noun-0]|TX|4021/1,4037/2|
00000000|MMI|3.07|Curriculum Vitae|C1880201|[inpr]|["Resume"-tx-11-"RESUME"-noun-0]|TX|3130/6|
00000000|MMI|3.07|Resume - Remote control command|C1550028|[idcn]|["Resume"-tx-11-"RESUME"-noun-0]|TX|3130/6|
00000000|MMI|3.07|resume - DataOperation|C3242342|[ftcn]|["resume"-tx-11-"RESUME"-noun-0]|TX|3130/6|
00000000|MMI|3.07|Local -Managed care POS|C3496399|[hcro]|["POS"-tx-18-"pos"-noun-0]|TX|3717/3|
00000000|MMI|3.07|Point-of-service (POS) plan|C3496112|[hcro]|["POS"-tx-18-"pos"-noun-0]|TX|3717/3|
00000000|MMI|3.06|SCN5A gene|C1419864|[gngm]|["IVF"-tx-37-"IVFs"-noun-0]|TX|5242/4|
00000000|MMI|3.06|Clinical Study Follow-up|C3274571|[hlca]|["FOLLOW-UP"-tx-10-"FOLLOW UP"-adj-0]|TX|2573/9|
00000000|MMI|3.06|Discontinued|C1444662|[fndg]|["D/C"-tx-1-"D/C"-noun-1]|TX|195/3|
00000000|MMI|3.06|Doctor of Chiropractic|C1512015|[inpr]|["D.C."-tx-1-"D/C"-noun-0]|TX|195/3|
00000000|MMI|3.06|Follow-Up Report|C1704685|[inpr]|["Follow-Up"-tx-10-"FOLLOW UP"-adj-0]|TX|2573/9|
00000000|MMI|3.06|Follow-up status|C0589120|[fndg]|["Follow-up"-tx-10-"FOLLOW UP"-adj-0]|TX|2573/9|
00000000|MMI|3.06|follow-up|C1522577|[hlca]|["Follow Up"-tx-10-"FOLLOW UP"-adj-0]|TX|2573/9|
00000000|MMI|3.03|1/3 meter (distance vision finding)|C0475806|[fndg]|["Near"-tx-26-"near"-adj-0]|TX|4572/4|
00000000|MMI|3.03|23|C0450348|[qnco]|["23"-tx-7-"23"-integer-0]|TX|1502/2|
00000000|MMI|3.03|Cancer/Testis Antigen|C3813556|[aapp]|["CTA"-tx-20-"CTA"-noun-0]|TX|3918/3|
00000000|MMI|3.03|Causing|C0678227|[ftcn]|["Causing"-tx-11-"Causing"-adj-0]|TX|2767/7|
00000000|MMI|3.03|Diagnosis Type - Final|C1546485|[idcn]|["Final"-tx-1-"FINAL"-adj-0]|TX|33/5|
00000000|MMI|3.03|Electrocardiogram: right bundle branch block|C0344421|[fndg]|["RBBB"-tx-21-"RBBB"-noun-0]|TX|4116/4|
00000000|MMI|3.03|End-stage|C0205088|[qlco]|["Final"-tx-1-"FINAL"-adj-0]|TX|33/5|
00000000|MMI|3.03|Final|C3853528|[tmco]|["Final"-tx-1-"FINAL"-adj-0]|TX|33/5|
00000000|MMI|3.03|Last|C1517741|[qlco]|["Last"-tx-14-"last"-adj-0]|TX|3415/4|
00000000|MMI|3.03|Low Mitosis-Karyorrhexis Index|C3890211|[qnco]|["Low"-tx-14-"low"-adj-0]|TX|3347/3|
00000000|MMI|3.03|Near|C1706276|[qlco]|["Near"-tx-26-"near"-adj-0]|TX|4572/4|
00000000|MMI|3.03|PCYT1A wt Allele|C3540513|[gngm]|["CTA"-tx-20-"CTA"-noun-0]|TX|3918/3|
00000000|MMI|3.03|Precursor B-cell lymphoblastic leukemia|C1292769|[neop]|["c all"-tx-45-"call"-noun-0]|TX|5603/4|
00000000|MMI|3.03|Right bundle branch block|C0085615|[dsyn]|["RBBB"-tx-21-"RBBB"-noun-0]|TX|4116/4|
00000000|MMI|3.03|Yes (indicator)|C1705108|[cnce]|["YES"-tx-1-"YES"-noun-0]|TX|233/3|
00000000|MMI|3.03|Yes - Yes/no indicator|C1549445|[idcn]|["Yes"-tx-1-"YES"-noun-0]|TX|233/3|
00000000|MMI|3.03|day|C0439228|[tmco]|["DAY"-tx-10-"DAY"-noun-0]|TX|2409/3|
00000000|MMI|3.03|dictated - DocumentCompletion|C1609990|[idcn]|["Dictated"-tx-49-"dictated"-adj-0]|TX|5816/8|
00000000|MMI|3.03|dictated - ParticipationMode|C1548384|[ftcn]|["dictated"-tx-49-"dictated"-adj-0]|TX|5816/8|
00000000|MMI|3.03|low|C0205251|[qlco]|["Low"-tx-14-"low"-adj-0]|TX|3347/3|
00000000|MMI|3.03|low confidentiality|C1550472|[inpr]|["low"-tx-14-"low"-adj-0]|TX|3347/3|
00000000|MMI|3.03|low exposure|C4048187|[qlco]|["low"-tx-14-"low"-adj-0]|TX|3347/3|
00000000|MMI|3.03|per day|C0439505|[tmco]|["/day"-tx-10-"DAY"-noun-0]|TX|2409/3|
00000000|MMI|3.03|IFIH1 gene|C1537399|[gngm]|["MDA-5"-tx-9-"mda 5"-noun-0]|TX|2040/3,2080/1|
00000000|MMI|3.03|IFIH1 wt Allele|C3888243|[gngm]|["MDA-5"-tx-9-"mda 5"-noun-0]|TX|2040/3,2080/1|
00000000|MMI|3.01|3 Days|C1442459|[tmco]|["3D"-tx-16-"3d"-adj-0]|TX|3637/2|
00000000|MMI|3.01|ARID1A wt Allele|C2985160|[gngm]|["hELD"-tx-24-"Held"-adj-0]|TX|4339/4|
00000000|MMI|3.01|Complete Response with Incomplete Bone Marrow Recovery|C3538993|[fndg]|["CRi"-tx-37-"CRI"-noun-0]|TX|5163/3|
00000000|MMI|3.01|Cranial Rhythmic Impulse|C1704519|[phsf]|["CRI"-tx-37-"CRI"-noun-0]|TX|5163/3|
00000000|MMI|3.01|Full|C0443225|[qlco]|["Full"-tx-4-"Full"-adj-0]|TX|302/4|
00000000|MMI|3.01|Has difficulty doing (qualifier value)|C1299586|[fndg]|["difficulties"-tx-29-"difficulties"-noun-0]|TX|4823/12|
00000000|MMI|3.01|Held - activity status|C1948036|[idcn]|["held"-tx-24-"Held"-adj-0]|TX|4339/4|
00000000|MMI|3.01|Importance Weight|C1705104|[idcn]|["Weight"-tx-10-"weight"-noun-0]|TX|2442/6|
00000000|MMI|3.01|PET Scanner 3D Mode|C2986797|[ftcn]|["3D"-tx-16-"3d"-adj-0]|TX|3637/2|
00000000|MMI|3.01|Prolonged|C0439590|[tmco]|["Prolonged"-tx-29-"prolonged"-adj-0]|TX|4836/9|
00000000|MMI|3.01|RNH1 gene|C1826843|[gngm]|["CRI"-tx-37-"CRI"-noun-0]|TX|5163/3|
00000000|MMI|3.01|Reduced|C0392756|[qlco]|["Reduced"-tx-20-"reduced"-adj-0]|TX|4089/7|
00000000|MMI|3.01|Slight (qualifier value)|C2937276|[qlco]|["Slightly"-tx-20-"slightly"-adv-0]|TX|4080/8|
00000000|MMI|3.01|Slightly (qualifier value)|C0750482|[qlco]|["Slightly"-tx-20-"slightly"-adv-0]|TX|4080/8|
00000000|MMI|3.01|Three-dimensional|C0450363|[spco]|["3D"-tx-16-"3d"-adj-0]|TX|3637/2|
00000000|MMI|3.01|Unable|C1299582|[fndg]|["Unable"-tx-14-"unable"-adj-0]|TX|3455/6|
00000000|MMI|3.01|Weighing patient|C1305866|[diap]|["weight"-tx-10-"weight"-noun-0]|TX|2442/6|
00000000|MMI|3.01|Weight|C0043100|[qnco]|["WEIGHT"-tx-10-"weight"-noun-0]|TX|2442/6|
00000000|MMI|3.01|saw (device)|C0183089|[medd]|["SAW"-tx-13-"saw"-noun-0]|TX|3329/3|
00000000|MMI|3.01|Amlodipine 5 MG|C1124796|[clnd]|["Amlodipine 5 MG"-tx-6-"AMLODIPINE 5 MG"-noun-0]|TX|1133/15|
00000000|MMI|3.00|Oxycodone 10 MG|C1126285|[clnd]|["Oxycodone 10 MG"-tx-5-"OXYCODONE 10 MG"-noun-0]|TX|816/9,828/5|
00000000|MMI|3.00|Adverse Event Emergency Room Visit|C3810541|[inbe]|["ER"-tx-7-"ER"-noun-0]|TX|1246/2|
00000000|MMI|3.00|Estrogen Receptor Measurement|C3811131|[lbpr]|["ER"-tx-7-"ER"-noun-0]|TX|1246/2|
00000000|MMI|3.00|Final Statistical Report|C3890900|[inpr]|["SR"-tx-7-"SR"-adj-0]|TX|1276/2|
00000000|MMI|3.00|Imdur|C0590690|[orch,phsu]|["Imdur"-tx-7-"IMDUR"-noun-0]|TX|1240/5|
00000000|MMI|3.00|Omeprazole 20 MG|C0988268|[clnd]|["Omeprazole 20 MG"-tx-9-"OMEPRAZOLE 20 MG"-noun-0]|TX|2044/16|
00000000|MMI|3.00|Primary|C0205225|[qlco]|["Principal"-tx-11-"PRINCIPAL"-adj-0]|TX|2708/9|
00000000|MMI|3.00|SR cell line|C3891546|[emod]|["SR"-tx-7-"SR"-adj-0]|TX|1276/2|
00000000|MMI|3.00|Skin Response Domain|C3813610|[inpr]|["SR"-tx-7-"SR"-adj-0]|TX|1276/2|
00000000|MMI|3.00|Sodium Cation|C0597484|[elii]|["Sodium+"-tx-10-"Sodium"-noun-0]|TX|2535/6|
00000000|MMI|3.00|Sodium Drug Class|C3714642|[phsu]|["SODIUM"-tx-10-"Sodium"-noun-0]|TX|2535/6|
00000000|MMI|3.00|Sodium supplements|C3541959|[phsu]|["Sodium"-tx-10-"Sodium"-noun-0]|TX|2535/6|
00000000|MMI|3.00|Teaching principal|C0401925|[prog]|["Principal"-tx-11-"PRINCIPAL"-adj-0]|TX|2708/9|
00000000|MMI|3.00|gram|C0439208|[qnco]|["GRAM"-tx-10-"gram"-noun-0]|TX|2530/4|
00000000|MMI|3.00|Arthropathy associated with infection|C0157749|[dsyn]|["Joint Infection"-tx-33-"joint infection"-noun-1]|TX|4978/15|
00000000|MMI|2.99|/40|C0439509|[tmco]|["/40"-tx-8-"40"-integer-0]|TX|1878/2|
00000000|MMI|2.99|40%|C3842587|[qnco]|["40%"-tx-8-"40"-integer-0]|TX|1878/2|
00000000|MMI|2.99|Anti-Drug Antibody|C3811629|[aapp,imft]|["ADA"-tx-10-"ADA"-noun-0]|TX|2505/3|
00000000|MMI|2.99|CA8 gene|C1413051|[gngm]|["CALS"-tx-10-"cals"-noun-0]|TX|2514/4|
00000000|MMI|2.99|Genus Ada|C1060325|[plnt]|["Ada"-tx-10-"ADA"-noun-0]|TX|2505/3|
00000000|MMI|2.99|Nutrition, Calories|C1556156|[qnco]|["cals"-tx-10-"cals"-noun-0]|TX|2514/4|
00000000|MMI|2.99|Study Day|C2826182|[tmco]|["DY"-tx-10-"dy"-noun-0]|TX|2519/2|
00000000|MMI|2.99|kilocalorie|C0439259|[qnco]|["Cal"-tx-10-"cals"-noun-0]|TX|2514/4|
00000000|MMI|2.99|Cholesterol measurement test|C0201950|[lbpr]|["CHOL"-tx-10-"chol"-noun-0]|TX|2473/4|
00000000|MMI|2.99|SAT1 protein, human|C2744672|[aapp,enzy]|["SAT"-tx-10-"sat"-noun-0]|TX|2482/3|
00000000|MMI|2.99|SAT1 wt Allele|C1705827|[gngm]|["SAT"-tx-10-"sat"-noun-0]|TX|2482/3|
00000000|MMI|2.99|Issue (document)|C1706387|[inpr]|["Issue"-tx-43-"issues"-noun-0]|TX|5377/6|
00000000|MMI|2.99|Problem|C0033213|[fndg]|["Issue"-tx-43-"issues"-noun-1]|TX|5377/6|
00000000|MMI|2.99|Data Port|C1880253|[cnce]|["Port"-tx-1-"Port"-noun-0]|TX|100/4|
00000000|MMI|2.99|Device Port Device Component|C1706409|[mnob]|["Port"-tx-1-"Port"-noun-0]|TX|100/4|
00000000|MMI|2.99|Harbor|C0475311|[mnob]|["port"-tx-1-"Port"-noun-0]|TX|100/4|
00000000|MMI|2.99|Port - alcoholic beverage|C0452253|[food]|["Port"-tx-1-"Port"-noun-0]|TX|100/4|
00000000|MMI|2.99|Food allergenic extracts|C3540798|[imft,phsu]|["food"-tx-7-"food"-noun-0]|TX|1410/4|
00000000|MMI|2.99|Room of building - Study|C0557651|[mnob]|["Study"-tx-11-"Study"-noun-0]|TX|2757/5|
00000000|MMI|2.99|Study|C2603343|[resa]|["Study"-tx-11-"Study"-noun-0]|TX|2757/5|
00000000|MMI|2.99|Every six hours|C0585325|[tmco]|["Q6H"-tx-5-"Q6H"-noun-0]|TX|837/3|
00000000|MMI|2.99|Pain NOS Adverse Event|C1962977|[fndg]|["Pain NOS"-tx-5-"Pain"-noun-0]|TX|845/4|
00000000|MMI|2.99|microgram|C0439211|[qnco]|["mcg"-tx-5-"MCG"-noun-0]|TX|803/3|
00000000|MMI|2.99|miscellaneous Crenarchaeota group|C3463985|[arch]|["MCG"-tx-5-"MCG"-noun-0]|TX|803/3|
00000000|MMI|2.98|IV dextrose|C3841860|[fndg]|["IV Glucose"-tx-11-"IV glucose"-noun-1]|TX|3113/10|
00000000|MMI|2.98|Two weeks|C4082118|[tmco]|["Two weeks"-tx-18-"two weeks"-noun-0]|TX|3836/9|
00000000|MMI|2.98|1800s|C0681738|[tmco]|["1800s"-tx-10-"1800"-integer-0]|TX|2509/4|
00000000|MMI|2.97|CDISC SDTM Evaluator Terminology|C2698624|[inpr]|["EVAL"-tx-48-"eval"-noun-0]|TX|5700/4|
00000000|MMI|2.97|Evaluator - personnel|C1707957|[prog]|["EVAL"-tx-48-"eval"-noun-0]|TX|5700/4|
00000000|MMI|2.97|Feeling relief|C0564405|[fndg]|["Relief"-tx-34-"relief"-noun-0]|TX|5074/6|
00000000|MMI|2.97|Highest|C1522410|[qlco]|["Apex"-tx-20-"apex"-noun-0]|TX|3991/4|
00000000|MMI|2.97|dinoflagellate apex|C3890171|[celc]|["apex"-tx-20-"apex"-noun-0]|TX|3991/4|
00000000|MMI|2.97|weekend|C0680190|[tmco]|["weekend"-tx-30-"weekend"-noun-0]|TX|4905/7|
00000000|MMI|2.97|TP-1|C0146275|[bacs,phsu]|["TP-1"-tx-7-"1 TP"-noun-0]|TX|1442/1,1453/2|
00000000|MMI|2.97|transition protein 1|C0146524|[aapp]|["TP-1"-tx-7-"1 TP"-noun-0]|TX|1442/1,1453/2|
00000000|MMI|2.97|Arylsulfatase A, human|C3853627|[aapp,enzy]|["ASA"-tx-36-"ASA"-noun-0]|TX|5109/3|
00000000|MMI|2.97|Lateral malleolus|C0448227|[bpoc]|["Lateral malleolus"-tx-20-"lateral malleolus"-noun-0]|TX|4047/17|
00000000|MMI|2.97|Behavior Rating Inventory of Executive Function|C4050216|[inpr]|["BRIEF"-tx-11-"BRIEF"-adj-0]|TX|3124/5|
00000000|MMI|2.97|Brief|C1879313|[tmco]|["Brief"-tx-11-"BRIEF"-adj-0]|TX|3124/5|
00000000|MMI|2.97|Infrequent|C0521114|[tmco]|["Infrequent"-tx-18-"infrequent"-adj-0]|TX|3804/10|
00000000|MMI|2.97|Past|C1444637|[tmco]|["Past"-tx-18-"past"-adj-0]|TX|3831/4|
00000000|MMI|2.97|Shortened|C1282927|[qlco]|["brief"-tx-11-"BRIEF"-adj-0]|TX|3124/5|
00000000|MMI|2.96|10%|C3842590|[fndg]|["10%"-tx-20-"10"-integer-0]|TX|3930/2|
00000000|MMI|2.96|Cough Adverse Event|C1961131|[fndg]|["Cough"-tx-18-"cough"-noun-0]|TX|3730/5|
00000000|MMI|2.96|Passive Range of Motion function|C0079991|[ortf]|["PROM"-tx-20-"prom"-noun-0]|TX|3945/4|
00000000|MMI|2.96|Programmable Read Only Memory Device Component|C1709700|[mnob]|["PROM"-tx-20-"prom"-noun-0]|TX|3945/4|
00000000|MMI|2.96|WASF1 gene|C1421479|[gngm]|["WAVE"-tx-20-"wave"-noun-0]|TX|3952/4|
00000000|MMI|2.96|wave - physical agent|C0678544|[npop]|["wave"-tx-20-"wave"-noun-0]|TX|3952/4|
00000000|MMI|2.96|0%|C3842591|[fndg]|["0%"-tx-7-"0"-percentage-0]|TX|1440/1|
00000000|MMI|2.96|Topical surface|C0332237|[spco]|["Topical"-tx-7-"TOPICAL"-adj-0]|TX|1445/7|
00000000|MMI|2.96|Benign|C0205183|[qlco]|["BENIGN"-tx-20-"benign"-adj-0]|TX|4012/6|
00000000|MMI|2.96|Emotional tenderness|C0684239|[menp]|["tenderness"-tx-20-"tenderness"-noun-0]|TX|4065/10|
00000000|MMI|2.96|HPS4 gen